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The Advisory Board on Radiation and Worker Health 

National Institute for Occupational Safety and Health 

Centers for Disease Control and Prevention 

Summary Minutes of the Thirty-fifth Meeting 

January 24-26, 2006 

The Thirty-fifth Meeting of the Advisory Board on Radiation and Worker 

Health (ABRWH or the Board) was held at The Doubletree Oak Ridge, Oak 

Ridge, Tennessee, January 24-26, 2006. The meeting was called by the 

Centers for Disease Control and Prevention (CDC’s) National Institute 

for Occupational Health and Safety (NIOSH), the agency charged with 

administering the ABRWH. These summary minutes, as well as a verbatim 

transcript certified by a court reporter, are available on the 

internet on the NIOSH/Office of Compensation Analysis and Support 

(OCAS) web site located at www.cdc.gov/niosh/ocas. Those present and 

who identified themselves included the following: 

ABRWH Members:  Dr. Paul Ziemer; Chair; Dr. Henry Anderson; Dr. Roy 

DeHart; Mr. Richard Espinosa; Mr. Michael Gibson; Mr. Mark Griffon; 

Dr. James Melius; Ms. Wanda Munn; Mr. Robert Presley; and Dr. 

Genevieve Roessler 

Designated Federal Official:  Dr. Lewis Wade, Executive Secretary 

Federal Agency Attendees: 

Department of Health and Human Services: 

Mr. Jason Broehm, Ms. Chia-Chia Chang, Mr. Larry Elliott, Ms. Chris 

Ellison, Mr. Stuart Hinnefeld, Ms. Liz Homoki-Titus, Ms. Emily Howell, 

Mr. Ted Katz, Dr. Jim Neton, Mr. David Staudt, Dr. Brant Ulsh 

Department of Labor: 

Dr. Diane Case, Mr. Peter Turcic 

Congressional Representatives: Ms. Elizabeth Howell, Ms. Livia Lam, 

Ms. Jennifer Stansbury 

Contractors:

Oak Ridge Associated Universities: Ms. Kate Kimpan, Mr. Bill 

Tankersley 

Stanford Cohen and Associates: Dr. Hans Behling, Ms. Kathy Behling, 

Mr. Joe Fitzgerald, Dr. Arjun Makhijani, Dr. John Mauro 

Public Attendees:  See Registration. 
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* * * * * 

Tuesday, January 24, 2006
 
Dr. Paul Ziemer, Chairman of the Advisory Board on Radiation and 

Worker Health, called the meeting to order noting that most members of 

this Board have been members since it began its series of meetings in 

January, 2002. Retiring members will be recognized later in the 

meeting. Present are three individuals recently named by the White 

House as new appointees to this Board: Mr. Brad Clawson from Idaho 

National Laboratory; Dr. Jim Lockey of the University of Cincinnati 

Medical Center; and Professor John Poston from Texas A&M University. 

They will be at the next meeting in April; today they are observing. 

Dr. Ziemer welcomed their participation. 

Dr. Lewis Wade, the Designated Federal Official, introduced Ms. Kate 

Kimpan, the new Project Director for Oak Ridge Associated Universities 

(ORAU), who will be replacing Dr. Richard Toohey. She will serve as 

the principal ORAU contact to NIOSH. Dr. Wade thanked Dr. Toohey for 

his contribution. 

Dr. Ziemer requested registration by all attendees and sign ups for 

today’s public comment period. Although the Board does not deal with 

individual claims, NIOSH staff members are available to assist in 

answering related questions. The Chair deferred approval of the 

minutes until Board members receive and read them, with action likely 

be taken Thursday afternoon. 

***** 

Dr. Wade clarified conflict of interest issues and then gave context 

for the Y-12 discussions. Conflicts of interest are expected to exist 

on the Board as it is comprised of people with valuable experience at 

the sites in question. Board members with conflicts for the Y-12 site 

profile are Dr. Roy DeHart, Mr. Robert Presley and Mr. Mark Griffon
 
B- Mr. Griffon only when there are issues pertaining directly to the 
Atomic Trades and Labor Council. The policy with regard to conflict 
of interest on site profiles allows conflicted Board members to 
participate in table discussions but prohibits their making or voting 
on motions. 
*****
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Y-12 NATIONAL SECURITY COMPLEX 

SITE PROFILE DISCUSSION/PLAN OF ACTION 

Mr. Joe Fitzgerald, 

Sanford Cohen & Associates 

Mr. Fitzgerald presented an overview of the issue resolutions for the 

Y-12 site profile, one of the first profiles to be reviewed by the 

Board's contractor. The review is aggressive. Of particular urgency is 

the site profile technical issues relating to a subclass of workers: 

steamfitters, pipefitters, and plumbers who worked from October, 1944 

through December, 1957. The Board desires to bring a timely resolution 

to that portion of a pending SEC petition. This Board earlier 

recommended approval of a petition for Y-12 employees who worked in 

uranium enrichment or other radiological activities from March, 1943 

through December, 1947. The Secretary of the Department of Health 

and Human Services (HHS) has acted positively on that recommendation. 

The Board intends to resolve these technical issues and bring the 

portion of the petition that has not been acted upon to a vote at the 

April Board meeting. 

Mr. Fitzgerald urged resolution of remaining issues so the Board will 

have necessary guidance and technical support for making a decision on 

the petition. He gave a chronology of Board, SC&A and NIOSH 

interactions aimed at narrowing issues and differences and producing 

resolutions. These entities have been meeting or conferencing almost 

monthly with robust analysis and data-gathering in the meantime. Key 

issues for both the SEC petition and the site profile reviews begin 

with data validity or reliability to assure that data used for dose 

reconstruction can be validated as representative of the plant, time 

period and processes. SC&A and NIOSH have not given up on obtaining 

some data from the files in Atlanta or elsewhere which might give a 

better handle on this issue, but so far the search has not proven 

fruitful. Various compensatory sources can provide some measure and 

test of consistency. Reliability of data is essential to the issue of 

adding a class to the Special Exposure Cohort. 

A second issue is that the scope of review for the site did not 

narrowly consider Y-12 to be a uranium plant. Y-12 is one of many 

Department of Energy (DOE) sites with a diverse history including 

numerous activities with Cyclotron and Calutron in terms of generating 

different radioisotopes, handling plutonium -- in short a number of 

sources of radiation other than uranium. The focus now is how that may 

have contributed to the overall source term for the plant. The 

implications are important in the SEC petition context, as the class 

of workers in question may have moved throughout the plant and been 

exposed to non-uranium sources. SC&A is concerned about the lack of 
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any database to help clarify this issue. NIOSH is making available 

this week 6,000 pages of bioassay data from the X-10 side of the plant 

which can inform this analysis for identifying an appropriate coworker 

model. However, even if the bioassay data proves to be reliable, it 

will not answer all questions. As regards SEC petition consideration, 

resolution of this issue would assure that all the sources were 

accounted for in relation to this mobile worker class which includes 

pipefitters, plumbers and others. 

Regarding job functions, NIOSH has provided immensely helpful 

information for determining dose distribution by virtue of job titles 

and categories. SC&A finds difficult to accept that the population 

under consideration is homogeneous with similar exposures. Instead, 

the exposure potential is actually higher than the average, a broad 

mean somewhere between 50 and 95 percent which needs continued 

examination. The working group has had good discussions about what the 

data indicates. The most useful practice is to actually look at the 

data and determine if the 50th percentile is appropriate or perhaps to 

take a more conservative approach and handle certain job categories 

separately. This determination could be facilitated with information 

on departments. While this matter may not be primary for upcoming 

discussions or the SEC petition, it is important for dose 

reconstruction. 

Next, Mr. Fitzgerald moved on to three action items that SC&A took 

from the January 5th workgroup meeting. 

1. The first item was to review factors used in Table 5-2 through 5­
8 dealing with parameters on recycled uranium, with more on that 

later. 

2. The second item was the 147 dose records from monitored workers 

used in the regressive statistical analysis and whether in fact that 

model was representative. This analysis took data from the 1960’s and 

applied it to the 1950’s for which data is sparse. 

Dr. Ziemer paused the presentation to notify Board members that 

comments on January 19th were distributed via e-mail. Those comments 

will be made available today to the public. 

3. The third action item was the OTIB-51 which deals with how to 

arrive at correction factors for early NTA film and angular dependence 

so that dose estimates can be accurately determined. Those comments 

were provided on the 19th . This issue was raised not only for the Y­
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12 site profile but also during the past three reviews worked on by 

Dr. Hans Behling and Ms. Kathy Behling. It would be a fundamental step 

forward to have OTIB-51 contain this information and provide these 

factors. He said the approach is sound but the analysis should be run 

for energies beyond 700 keV; 800 and 900 offer other benchmarks and 

it might be appropriate to have additional curves provided. This is a 

loose-end issue. The chemical operators were appropriately considered 

in the analysis but whether by oversight or intention were not cited 

in method two, and he would like to find out about that. The OTIB did 

not address some issues relative to neutron flux below the NTA 

threshold. Site-wide workers at Y-12 may have been exposed to those 

thermal neutrons. The preceding are very specific technical comments. 

Mr. Fitzgerald expressed general support for the approach provided in 

the OTIB. 

4. Also of note is the action item concerning revisiting the tables 

in the TBD for Y-12 dealing with recycled uranium. Comments center on 

whether one can be very generic or whether current data would support 

generation of more tailored information for particular operations and 

processes. He also raised the question on whether badging was based on 

maximum exposure workers. Although SC&A hasn't seen the 147 dose 

records, they are beginning to go through the expanded CER database 

through 1965. They feel that some of the lower numbers just below 

1,000 millirem per quarter suggest a group of workers who may not have 

been maximally exposed in the early period. There are appreciable 

differences in the numbers at the pre-criticality/post-criticality 

juncture. The data is not conclusive but does suggest that a sub-group 

of workers who were not badged may have been maximally exposed or 

there may have been cohort badging in certain activities. This issue 

is similar to one relative to bioassay and whether one can be assured 

that this is not random sampling on a department-wide basis. SC&A 

will focus on the reliability, robustness and applicability of the 

6,000 pages of X-10 data. Along with NIOSH, they will examine what the 

data suggests to determine whether U-233, radon and other nuclides 

elsewhere in the plant would be significant in helping answer that 

question and in corroborating the reliability of the electronic 

database. The review calls for clarity in determining whether or not 

the basis for coworker models and the maximally exposed individuals 

can be established. 

In SC&A’s view, everything else is clearly appropriate for a site 

profile. The detailed review contains over 100 findings, many of which 

are factual accuracy and technical issues not likely to bear on the 

SEC petition determination but important enough to be second priority. 

*** 
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Discussion began with Mr. Griffon seeking clarification from Dr. Jim 

Neton about the availability of a disk for SC&A and the Board. Dr. 

Neton will try to have an answer by the end of the day to expedite 

release of the disk. Dr. Ziemer said the document will be made 

available to the public before long. Dr. Henry Anderson then asked 

about whether a portion of the 6,000 records will be abstracted or by 

what means this information will be provided in a timely fashion. Dr. 

Neton said that not having seen the 6,000 records, he did not know, 

but the concept was that these records include data for radionuclides 

other than uranium, specifically plutonium and possibly polonium. 

NIOSH intends to gather enough data make a robust coworker matrix to 

apply to workers at processes such as the Calutron and the Cyclotron 

and other operations involving non-uranium activities, provided 

identification can be made of who was monitored for those nuclides. 

In addition to these 6,000 records, NIOSH is looking at Department 

4000 records from the X-10 facilities. Those are people who worked on 

operations at Y-12. These two datasets may provide the basis for some 

quality analyses that would allow dose reconstructions for non-uranium 

radionuclides at Y-12. Dr. Anderson asked for a time frame. Dr. Neton
 
replied that ORAU is currently reviewing the data, then it will be 

decided if the data can or cannot be used in a timely manner. 

Dr. Ziemer next reminded the Board of the conference call scheduled 

for March 14th. One of the items will be an update on the status of 

these issues for the Y-12 SEC petition and pertinent issues. At that 

point the Board must determine if it will be ready to have a vote on 

the petition for the April 25th through 27th full Board meeting. 

With issues fresh in mind and all parties present, Dr. Wade wanted to 

make detailed plans for interactions between NIOSH and SC&A to ready 

the vote on an SEC petition at the end of April. Mr. Robert Presley
 
found problematic the SEC petition’s mentioning of only pipefitters 

while leaving out large groups of workers who had likely worked with 

uranium issues, such as machinists and chemical workers, particularly 

considering that Y-12 was ramped up from a chemical operation into a 

production operation at that time. Mr. Larry Elliott clarified that 

the current language is only a starting point based on a definition 

put forward by the petitioner. During evaluations of petitions, the 

definition tends to expand to cover other site workers who should be 

considered in that class. He echoed the importance of resolving these 

issues because it goes directly to the first prong of the two-pronged 

test for considering adding a class B can dose be sufficiently 
reconstructed for that class. 
Dr. Ziemer asked if the job categories or individuals from Y-12 during 

the time period are well known, perhaps well established in the work 

records. Dr. Wade clarified for the record this discussion resides in 
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the context of the site profile evaluation. Mr. Presley said that in 

the past four or five years examining records he has come across a 

tremendous amount of job description material. He said Dr. Neton has a 

list up to 60 pages long in which the information exists to properly 

categorize jobs. Dr. Neton said the working group is aware of having 

a title for almost every exposure measurement in these exposure 

records; however, the titles were not standardized, so ORAU has made 

judicious choices in collapsing these data down from hundreds to 

perhaps 40 relevant job types. Dr. Neton also noted that the monitored 

workers seem to have been the more highly exposed. Mr. Griffon said 

that despite having job titles and work locations, a cross-link of 

where they worked is lacking. These possible multiple exposures might 

still be covered in a blanket distribution type model, but that level 

of detail is not currently available. Dr. Neton affirmed Mr. 

Griffon’s statements and said NIOSH is getting near the proof of the 

principle that these job categories can be collapsed. It will be 

difficult to decide who was potentially exposed to the non-uranium 

operations. If such workers cannot be binned into the right categories 

then the usual assumption that they could have been exposed will 

apply. These decisions can be made; the primary task is to identify 

how the group will go about it. These considerations are seen in the 

comment resolutions in the matrix B how NIOSH will use the 95th 
percentile, which categories of workers will go in there and specifics 
on the nuts and bolts of how this will be accomplished. 
Dr. Wade highlighted the importance of framing those nuts and bolts 

issues because this will be the Board’s last chance to instruct the 

principles in terms of the degree of specificity sought. Mr. Griffon
 
requested a few more examples from NIOSH on how the dose 

reconstruction models are applied to different situations, now that 

the working group has more data about other radionuclide issues. Dr. 

Wade and Dr. Ziemer agreed that this can all get done. Dr. Neton said 

he totally agrees with Mr.Griffon on the need for more examples. He 

also wanted make several points. Voluminous records exist for uranium 

urinalysis, film badge results and TLDs, and it will be a key task to 

establish the credibility or reliability of these datasets. 

Furthermore, although the presence of non-uranium nuclides must be 

considered, they were not routine operations and did not involve a 

major percentage of the workforce, despite the focus that issue is 

receiving. 

Thirdly, Dr. Neton wanted to be clear that the 6,000 page set of 

information is not full records but bioassay data, some full pages and 

some nearly blank and possibly some redundant pages. He did not want 

people’s expectations for this information to be too high. 
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Mr. Griffon commented that NIOSH had done at least a cursory analysis 

of the claimants and determined that about ten to 12 percent would 

rely on urinalysis records for dose reconstruction, whereas the other 

88 percent would rely at least to some extent on the coworker models. 

Dr. Neton continued, explaining that the further back one goes before 

1961, the more sparse the data. That means fewer and fewer samples 

are available thus necessitating the use of coworker data, which 

spotlights the issue of which percentile to use for coworker data. 

Whether to use 50th or 95th percentile is a matter of detail for the 

dose reconstruction process as opposed to something that would prevent 

doing a dose reconstruction at all. It is a matter for the working 

group. 

Dr. Ziemer expressed concern that the working groups remain ad hoc 

groups rather than becoming institutionalized as committees. He then 

asked the current working group to continue on the Y-12 site profile 

as it relates to the SEC petition, specifying along with Dr. Wade that 

the task relates only to the site profile, and working with SC&A and 

NIOSH in the resolution of identified issues. Dr. Ziemer asked the 

working group to make preparation for both the upcoming conference 

call and the next meeting. He asked Mr. Griffon to work out a 

schedule for the working group, NIOSH and SC&A. 

Dr. Wade noted that the upcoming suite of working group meetings would 

need to be available to representatives of the petitioner and those 

people who have a particular interest in these matters. Mr. Presley
 
asked if the site profile is to be considered from 1944 to 1957 or 

1943 to the present. There are years beyond 1957 that he feels should 

be looked at. Dr. Ziemer said the petition itself covers 1944 to 1957, 

period. Ms. Munn felt the site profile should run from initial 

operations to the current date, although the immediate priority would 

be those questions affecting the period of time covered by the SEC 

petition. Dr. Wade emphasized that the working group will only be 

looking at the site profile, even though they are likely to focus on 

certain areas for reasons of the SEC petition. Their task is the site 

profile review, not an SEC petition activity. Otherwise, the workgroup 

would have to be reconstituted. Dr. Ziemer said to proceed on that 

basis. 

***** 
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PROCEDURES FOR BOARD EVALUATIONS OF SEC PETITIONS 

DISCUSSION, PART I 

Dr. James Melius, Chair 

Special Exposure Cohort Review working group 

Dr. Melius presented the revised version of the January 9th conference 

call report on SEC petition procedures along with subsequently 

collected comments from the Board. The working draft report was 

produced from Dr. Wade’s outline of a half-day November workgroup 

meeting in Cincinnati with Dr. DeHart, Mr. Griffon, Dr. Ziemer and Dr. 

Melius along with several members of NIOSH staff. The purpose of this 

working group report is to streamline the petition evaluation process, 

particularly steps three and four. Comments of other Board members and 

the public are welcome following the presentation. 

Dr. Melius noted this is a simplified schematic of the steps in the 

petition process. First, the SEC petition is sent to NIOSH. 

Secondly, the petition is reviewed to see if it qualifies, and 

thirdly, after it has been accepted and deemed appropriate for follow-

up, NIOSH does an evaluation of the petition to determine if it meets 

SEC requirements to be a member of the cohort. Fourthly, the NIOSH 

evaluation report is transmitted to the Board for review. In simple 

terms, based on its review, the Board then makes a recommendation to 

the Secretary on whether or not to accept that group as a class into 

the Special Exposure Cohort. 

The workgroup had focused on steps three and four, namely how NIOSH 

conducts its evaluation of an accepted petition and how the Board 

reviews that evaluation. Their goal was to clarify the steps and 

increase efficiency because the petition process has required several 

meetings for deliberations and much work in between meetings to reach 

conclusions. They first focused on the steps from evaluation to 

recommendation, making the assumption for purposes of this report that 

the current regulations regarding the SEC qualifications stay in 

place. The main task at hand was to clarify the criteria and the 

procedures the Board would use in reviewing the NIOSH petition 

evaluation report to expedite the process without compromising the 

scientific basis. 

The workgroup arrived at four considerations. One: timeliness, so 

petitioners would not have to wait too long for a review and to reduce 

the Board and NIOSH’s time and effort. Second: fairness, to ensure 

each petition gets due effort in evaluation and review. Third: 

criteria understandable for the public and everyone involved. Fourth: 

consistency, or application of the same criteria to each petition to 

ensure equal treatment for all sites. 

9
 
   
 
 
 
 
 
 
 
 
 
           Summary Minutes January 24-26, 2006 

NIOSH/CDC Advisory Board on Radiation and Worker Health 

A key point is that these evaluations focus on exposure data sets, 

such as biological testing and external radiation sources collected 

over a period of time. The workgroup dealt with how to evaluate the 

credibility and validity of each data set in question. To that end 

they concern themselves with pedigree of that data, its quality, how 

it is generated; the methodology, whether up-to-date or not and how 

methods from 50 years ago compare to current ones; how to assess 

quality control from decades past and monitoring methods which were 

under development, and the relationship of the data under 

consideration to other sources of exposure information about the 

facility or the workers. Although some of these data sources may not 

be as comprehensive as the set intended for current use in individual 

dose reconstruction, the data need to point to the same thing. 

Internal consistency is needed. The basic dataset needs to make sense 

based upon what is known about the facility’s operations as well as 

the methods used for monitoring. Another key consideration is the 

representativeness of the data and whether they cover all areas of the 

facility. Monitoring in only one portion, for example, may not be 

applicable to exposures elsewhere in the facility. 

This group is also interested in whether the data adequately cover all 

time periods of interest in the petition and whether the dataset can 

be used to calculate individual doses during a given time period or 

are there gaps in data. Much time is spent trying to figure out the 

time span fairly and reliably covered by particular datasets. 

Another point of focus concerns whether the dataset can be generalized 

or used to cover mobile workers with varied tasks. If it does not, 

there are options in terms of splitting up the Special Exposure Cohort 

or accessing other appropriate datasets. The group also put focus on 

subsets of the data and how robust the data can be as it gets broken 

down into smaller and smaller subsets. 

Regarding data, Dr. Melius said the use of several different sets of 

data is usually not simple. There is a need to be able to focus on 

key sets of data critical to assessing whether or not individual dose 

reconstruction can be conducted reasonably within the constraints of 

timeliness, accuracy and fairness to the exposed workers. Feasibility 

points to readily available data. Timeliness requires access to the 

data and calculations necessary to do dose reconstruction without 

waiting years. Fairness requires that NIOSH demonstrate not only the 

ability to dose reconstruction but also the ability to appropriately 

reconstruct doses for all the different groups covered under the 

Special Cohort petition or evaluation. 
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Additionally, in recent evaluations of Special Exposure Cohort reports 

NIOSH has been asked for sample dose reconstructions using actual 

representative data. These demonstrations show that it is possible to 

do dose reconstruction for the various groups involved. The workgroup 

report contains further discussion to try to set out the criteria for 

this. 

The report also recommends a couple of procedural changes. One is that 

NIOSH provide a mid-point evaluation done after the petition has been 

certified. Currently, as soon as a petition is qualified, NIOSH 

prepares a very general report on their plans for doing the 

evaluation. It is general because NIOSH has not had time to look at 

the different datasets. A more detailed evaluation plan later in the 

process would be helpful both for NIOSH and the Board in reviewing the 

evaluation. This mid-point report could specify what datasets and 

types of information were going to be critical in assessing whether or 

not dose reconstruction is possible or whether the group would qualify 

to be part of the Special Exposure Cohort. 

A second recommendation, whenever possible, would be to complete a 

site profile before evaluation of a petition from that site, or at 

least review relevant portions of the site profile, because that 

information is very helpful in resolving issues about the petition 

evaluation. Admittedly, this must be done on a case by case basis. The 

Board’s contractor could also be asked to follow a procedural approach 

appropriate for the Board’s review of the SEC petitions, thus 

increasing efficiency and fairness. 

Dr. Ziemer asked Board members for questions, comments or concerns 

about the document. Dr. DeHart wanted to be sure the public 

understands that an SEC petition could be divided and sub-grouped so 

that one group would be certified and another group would wait for 

determination on calculation of dose. Dr. Melius added that even 

within the petition the groups could be sub-grouped; in fact that has 

already been done by demarcating different time periods of exposure, 

and NIOSH already does this to some extent. 

Dr. Wade offered comments. Tomorrow, SC&A will present recommended 

procedures for the Board to follow which will mesh well with today’s 

discussion. SC&A will also report on its initial review of NIOSH’s 

procedures in terms of reviewing the SEC petitions, so that will 

inform the discussion. He reminded the group that they’re an advisory 

committee to the Secretary of HHS, and when he briefed the Secretary’s 

advisors on the agenda for this meeting, they were very interested in 

this item in particular and had some thoughts to share. They do want 

to give this important issue a full vetting. They want to be sure 

incoming Board members have an opportunity to participate in this 
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process by which they will be governed. He suggested that as 

background for this discussion he can ask counsel tomorrow to address 

what timeliness means in the context of the Rule and of the law and 

applauded the working group’s willingness to work on this very 

important issue. 

***** 

INDIVIDUAL DOSE RECONSTRUCTION REVIEWS (SETS 1, 2 AND 3) 

Dr. Hans Behling, 

Ms. Kathy Behling, 

Sanford Cohen & Associates 

Concerning the first set of 20 cases, Ms. Behling reported that all 

have been reviewed and put through the full resolution process. She 

was not sure if the Board had any final issues to be addressed, 

although she believed there was a discussion point on a possible 

letter for the HHS. The report on the second set of 18 cases has been 

submitted, Board meetings have been held, and the working group met 

with NIOSH to discuss the associated findings. SC&A was hoping to get 

the written responses from NIOSH prior to this meeting but these have 

not yet been reviewed. For the third set of 22 cases, SC&A has 

submitted a draft report and held a conference call with the assigned 

Board members. Changes based on those comments have been made and 

SC&A’s matrix regarding the associated findings was recently submitted 

to the Board and NIOSH. 

Currently SC&A is nearing completion on the fourth set of 20 cases. 

Ms. Behling said SC&A is hoping during this meeting to establish a 

more efficient process of sending out individual reports with the 

assigned Board members and having discussion with them prior to 

publishing the report. SC&A will possibly be in a position to set up 

those meetings the second week in February. 

Ms. Behling offered an overview of the third set for the benefit of 

new Board members and as a reminder to all present of the stops 

involved in the dose reconstruction process. First, SC&A looks at the 

data studied by NIOSH and ORAU. They take NIOSH’s Interactive 

RadioEpidemiological Program (IREP) input sheets and attempt to 

reproduce the doses. If they can’t reproduce all the doses, they do a 

spot check or a selection, a process to be detailed later on today. 

In addition to reconstructing the dose, SC&A examines whether or not 

the dose reconstructor correctly used, understood and applied the 
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appropriate procedure. They try to ensure that the regulations and 

assumptions used in the dose reconstructions are fair, consistent, 

well-grounded, and based on the best available science. 

Lastly, they check to see if all the data received and looked at by 

NIOSH appears on the Computer-Assisted Telephone Interview (CATI) 

report. They want to ensure that all the Department of Energy (DOE) 

records and any monitoring and bioassay data is being used to address 

all aspects of activity submitted by the claimant. For example, for 

the third set of cases, 20 of the 22 cases were considered advanced 

reviews. Looking at the CATI report enabled SC&A to make a 

determination and suggest areas in which SC&A and NIOSH could or could 

not expand on the information available. 

Ms. Behling noted that confusion abounds over the issue of which 

procedures are being used and how the entire dose reconstruction 

process goes forward. She explained that for dose reconstruction, it 

is first looked at by a group at ORAU that makes a determination based 

on the cancer and a preliminary look at the dose to fit it into one of 

three categories: 

#1Minimized dose reconstruction, which for the sake of efficiency does 

not have to calculate the entire dose because there is sufficient 

dose to put the individual over the 50 percent POC; 

#2The maximizing approach, most common in these 60 cases, where the 

dose reconstructor uses a set of procedures specific to that case 

and situation in attempt to show that the claimant does not go 

over the 50 percent POC even when receiving all the benefit of 

the doubt; 

#3and the last approach, to be covered by Dr. Behling at the end of 

this presentation, the best-estimate dose reconstruction. 

The fourth set of reviewed cases exemplified some true best-estimate 

dose reconstructions. NIOSH looks at all the records to make a 

painstaking and very detailed assessment for internal and external. 

Using IREP summary sheets to reproduce doses for these best-estimate 

cases has become much more tedious for SC&A reviewers due to the 

computer programs and workbooks used by the NIOSH dose reconstructors. 

Ms. Behling next broke down the categories of types of information 

used in the SC&A review checklist. For data collection issues they 

review whether NIOSH did get all the data they requested from DOE and 

had enough data including external, internal and CATI information to 

adequately complete this dose reconstruction. Misinterpretation of 

procedures is the root cause of 30 percent of the findings. Currently 
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ORAU is using the workbook dose reconstruction tools which provide an 

easier, much more efficient and consistent dose reconstruction 

approach than ever before. Many of the findings will be eliminated or 

at least reduced when the workbooks are used almost exclusively. 

Under Task III SC&A has begun to look at the workbooks and Ms. Behling 

noted it will be critical in the future to ensure that the workbooks 

are appropriately using the information in the procedures and in the 

Technical Basis Documents. The statistics on these 60 cases largely 

stays the same as last time, even given a few minor calculation 

errors, procedures not referenced and similar problems early on within 

the third set of 22 cases. The only significant change in statistics 

arises where, as reviewer, they could not reproduce the dose. In 

earlier findings that number was two percent, and now the number is 14 

percent. When SC&A encountered for the first time a best-estimate done 

for the external dose, it raised many questions. SC&A didn't know the 

dose reconstructor was using a workbook and the reviewer ultimately 

was unable to reproduce a lot of information there, which raised the 

statistic. 

Dr. Ziemer asked what number of findings would have resulted in a 

change to the compensation of a worker. Dr. Behling said that of all 

60 cases to date, he could say with a high degree of certainty that 

not one of them would be changed. Ms. Behling elaborated on an 

earlier comment that much conservatism is built into these maximum 

dose reconstructions and that reassessments for neutron doses will be 

based on best-estimate procedures rather than ORAU TIB 2, 8 and 10. 

The benefit of these 60 cases has been to give the dose reconstructor 

the option of doing the dose reconstruction manually, using the 

aforementioned procedures. This process facilitated part of Task III, 

to identify where the procedures are unclear and complex. NIOSH has 

conceded they will try to clarify the procedures, which will address 

the finding concerning misinterpretation of procedures in 30 percent 

of cases. 

Dr. Behling summarized what they have learned to date. Having reviewed 

almost all of the four sets, they can conclude that most of the audits 

were maximized, assigning far more dose than would reasonably have 

been received. Only a few cases involved partial dose reconstructions 

needed to get over the 50 percent mark. The impact of findings 

concerning a deficiency, a few missed doses, is overshadowed by the 

huge dose that has been assigned. It comes to the point where in 

context with these errors one approaches or exceeds 50 percent and 

NIOSH has recourse to say the gift is coming back. 

Nevertheless, these findings do point to things which need to be 

looked at for the sake of process credibility. It does not look right 
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to continuously commit the same errors even if they are marginal 

errors with no impact. The checklist has made that clear; the 

reviewers do not anticipate anything that would potentially have 

converted a non-compensable to a compensable case. 

For the first time, Dr. Behling said, we have encountered the best-

estimate methodology, which is impressive for its detail and 

complexity. It must be very tedious for the dose reconstructor who 

must actually model and assess a volume of records decades in the 

making. That is time-consuming for the dose reconstructor and the 

reviewers. Now, best estimates are usually invoked in situations where 

the potential exposures will lead to a POC of between 45 and 50 

percent. This calls for great care in looking at every aspect of the 

dose reconstruction process, because there is no buffer. 

SC&A will not do the POC calculation. That will go back to NIOSH. 

However, there will be some instances of 48 POC and the findings will 

be dangerously close if not over that limit. SC&A will not proceed 

beyond the point of identifying these findings. Dose audits are at a 

new position wherein more and more best estimates will be used, 

requiring much more detailed scrutiny for the assessment. The use of 

workbooks has all but eliminated many of the errors found under the 

min/max approach. They are extremely useful and relatively easily 

audited. Their use of computer codes--Crystal Ball-- to calculate 

uncertainty will eliminate many of the concerns found in the first 60 

cases, where few people could understand the procedures for 

determining uncertainty. Dr. Wade thanked them for their presentation. 

***
 
In the brief comment period afterward, Dr. Ziemer and Dr. Wade
 
ascertained that NIOSH has provided responses on cases 21 through 30 

but nothing beyond that so tomorrow the workgroup will place a 

different course of action for each of the 20 sets, bringing them to 

resolution and closure. Dr. Ziemer announced the public comments 

period will start an hour earlier than scheduled but assured everyone 

that it would still be in session at the designated start time of 5:30 

p.m. today. 

***** 

PUBLIC COMMENT PERIOD 
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Dr. Ziemer offered remarks and ground rules. He called for concise 

comment and said the Board is seeking to identify if the system is 

working well and where fixes are needed. He reminded the public that 

this Board does not do the dose reconstructions or determine who is 

eligible for compensation, nor does it review denied cases. This is 

not an appeals board. Its well-defined responsibilities include 

reviewing the work of NIOSH to ensure adherence to proper procedures. 

For detailed concerns about an individual case, members of the public 

can talk to NIOSH people who are available here today to provide or 

obtain information and answers. Dr. Ziemer then took public comment 

in the order of the sign-ups. 

The following is the list of the members of the public who spoke. A 

full transcript of the public comment is available on the OCAS web 

site, www.cdc.gov/niosh/ocas. 

Mr. Larry Jones, ATLC health and safety representative, Y-12; Ms. 

Barbara Walton, Bethlehem Steel survivor; Ms. Kathy Bates, daughter of 

survivor; Ms. Janet Michele*, Coalition for a Healthy Environment and 

the Alliance for Nuclear Worker Advocacy Groups; Ms. JoNell Barton, 

claimant; Ms. Doris Henline, claimant; Ms. R. L. Ayers, survivor; Mr. 

George Eldridge, survivor; Mr. Gary Foster, son of claimant; Mr. 

Forrest Johnson, claimant; Mr. Kenny Cook, ATLC; Ms. Eliza Robinson, 

claimant; Mr. Bob Warren, claimants; attorney; Ms. Beulah Lindsey and 

Mr. Alvin Lindsey, survivor children; Mr. Glenn Bell, Chair, Y-12 

Chronic Beryllium Disease Support Group; Mr. Richard Miller, GAP. 

*****
 
With no further comments, the Board officially recessed until the 

following morning. 

***** 

Wednesday, January 25, 2006
 
Dr. Ziemer welcomed all to day two of the Advisory Board on Radiation 

and Worker Health in Oak Ridge, Tennessee, encouraging registration of 

attendance and sign ups for the public comment period at 7:30 tonight. 

Copies of today’s documents are available in the room. Board members 

should have received copies of minutes of the August and October 

meetings which will be reviewed tomorrow. Dr. Wade thanked the Board 

for its difficult work and commended the high level of transparency, 

which reflects well on the quality as well as the quantity of the 

work. 
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***** 

PACIFIC PROVING GROUNDS SPECIAL EXPOSURE COHORT 

No conflicts of interest on the Board were announced concerning the 

petition for Special Exposure Cohort by the petitioners for the 

Pacific Proving Grounds. Ms. Daniella Karo, representing the 

petitioners, was present via telephone, and Dr. Paul Blake was also 

present on behalf of the Defense Threat Reduction Agency (DTRA) which 

is involved in a counterpart program concerning compensation for 

atomic veterans. Board members were provided a recent document 

containing comments and concerns raised by DTRA to be discussed in 

connection with this petition. Dr. Wade added that Dr. Neton’s
 
presentation will be proof that there are no simple SEC petitions. 

Dr. James Neton, 

NIOSH/OCAS 

Dr. Neton addressed the evaluation of SEC Petition No. 20, received by 

NIOSH under a different definition. NIOSH is now evaluating the 

Pacific Proving Grounds in total and not just Operation HARDTACK 1, 

which was the basis for that petition. The Pacific Proving Grounds is 

a series of atolls and islands in the Marshall Islands where the U.S. 

military conducted a series of nuclear weapons tests from 1946 to 

1962, starting with Operation CROSSROADS and ending with DOMINIC. The 

petition received by NIOSH, initial class, was for all scientists and 

couriers employed at Enewetak Atoll during Operation HARDTACK from 

July 1st, 1958 through August 31st, 1958 -- a very narrow window of 

time. As is usual with petition evaluations, NIOSH looked beyond the 

established class to see if any additional exposure scenarios and time 

periods should be evaluated and possibly covered under the petition. 

Following the procedures and guidelines established by 42 CFR 83, the 

Special Exposure Cohort rule, a petition for SEC status was submitted 

for Pacific Proving Grounds and was qualified on April 11, 2005. The 

petitioners and the Board were notified, and a Federal Register notice 

was published on May 5, 2005. The NIOSH evaluation of the petition is 

summarized in their report of October 20, 2005, sent to both the 

petitioners and the Board. On January 18, 2006 a Federal Register 

notice advised that the report would be discussed by the Board at its 

upcoming meeting. 

In December Dr. Blake had written NIOSH expressing his concern that 

several misrepresentations in a Nuclear Regulatory Commission (NRC) 

report on DTRA's program may lead to misconceptions by NIOSH about the 

operating status of said program. On January 20 NIOSH filed a 
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supplement to their evaluation in which they attempted to address the 

issues raised and to slightly narrow both their proposed class 

definition and the focus of the petition. 

Dr. Neton reported that the required steps in the evaluation process 

included the application of the two-pronged test for feasibility and 

health endangerment. He described the types of data reviewed in 

determining feasibility, including the availability of resources. He 

explained the results of such efforts in determining if there were 

sufficient sources of ionizing radiation and how these sources were 

delivered in concluding whether workers' health could have been 

endangered through such exposures. 

NIOSH conversed by phone and later shared a site visit with DTRA 
personnel engaged in a similar program of dose reconstructions for 
military personnel who were at these test sites. NIOSH evaluated 
DTRA’s process for possible use in reconstructing doses for purposes 
of Energy Employees Occupational Illness Compensation Program
(EEOICPA.) DTRA’s example dose reconstructions used the ICRP-30 models 
for internal dose and estimated a 50-year committed dose rather than 
the annual doses NIOSH uses under this program for IREP calculations. 
Dr. Neton also noted that dose reconstructions for the DTRA’s Nuclear 
Test Personnel Review program are conducted for non-presumptive 
cancers. 
As for affidavits and documentation provided by the petitioners, there 

was no monitoring for internal exposure from ingestion or inhalation 

during these time periods and no evidence to link the considerable 

external data to internal exposure. NIOSH could not find bioassay 

sample records from Operation CROSSROADS, and the quality and 

reliability of that data was questioned in the publicly available 

records, as these measurements were done on board ship with available 

survey instruments, with no long-range plan for measurement. Data for 

off-site air sampling was insufficient to enable dose reconstruction 

for workers, as they were primarily environmental samples related to 

possible civilian exposures. 

When NIOSH found nothing available for bioassay sampling and the 

environmental monitoring data was insufficient, they looked to DTRA’s 

approach of using a sophisticated computer program to estimate 

internal dose from external dose results on the badge. However, in 

considering this whole program, NIOSH recognized that a lengthy 2003 

review by the National Research Council questioned the credibility of 

the upper bounds raised and the reliability of the methods. Although 

the NRC review did not invalidate the model in question, it raised 

questions about the multiple sources of uncertainty and whether the 

method is valid for making these assumptions. 
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Dr. Neton noted that in NIOSH’s review they were evaluating DTRA’s 

program only for purposes of reconstructing doses with sufficient 

accuracy under EEOICPA. They were not questioning DTRA’s ability to 

reconstruct doses for their own program. That finding and numerous 

others, however, indicated that doses could be either underestimated 

or overestimated, but the report made no real indication of the 

magnitude of corrections or the uncertainties in either direction, so 

sufficient accuracy cannot be assured. 

DTRA’s plan of action to evaluate these issues and complete their 

analysis was slated for June 2006. Although interim guidance issued 

July 16th allows DTRA to move forward with dose reconstructions by 

multiplying the internal doses by a factor of ten, NIOSH has not seen 

scientific analysis of that approach and feels it would not constitute 

sufficient accuracy under the requirements of this program. 

NIOSH then revised the class definition from covering Operation 

HARDTACK 1 to all employees of DOE, DOE contractors or subcontractors 

employed there from 1946 through 1962 who were monitored or should 

have been monitored for exposure to ionizing radiation as a result of 

nuclear weapons testing at the Pacific Proving Grounds. 

Sources of internal exposure from multiple detonations resulted from 

fallout contamination rather than direct exposure to the criticality 

event. Even though NIOSH believes health was endangered due to 

accumulated internal exposures through episodic intakes of 

radionuclides, they lack access to sufficient bioassay or air 

monitoring to properly estimate doses. 

Discussion ensued with Dr. Ziemer and Dr. Neton clarifying points. 

Some dose reconstructions were completed from this newly-defined class 

of 65 but under SEC regulations it turns out they lacked sufficient 

accuracy. 

Concerning DTRA’s suggestion of missed data sources, Dr. Ziemer asked 

if those new bioassay sources would be readily available at least for 

determination of usefulness. Dr. Neton said he’ll defer that question 

to the Department of Labor (DOL.) 

Dr. Melius questioned how an operational determination will be made 
regarding the SEC definition involving a Amonitored or should have 
been monitored.@ Dr. Neton explained that NIOSH held discussions with 
the DOL and decided to narrow the class of workers to those fitting 

this description who were actually exposed. Otherwise, site employees 

who did not even work in the presence of radioactive materials would 

be eligible. 
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Mr. Peter Turcic from the Department of Labor said the provision, 

present in all Congressionally-mandated SECs, is handled for all sites 

by occupation. The exception was Amchitka where it was handled by 

policy. 

Mr. Griffon asked if the DTRA case reviewed by NIOSH included internal 

dose estimates and whether those models could not credibly bound doses 

for claimants in this population. Dr. Neton replied that based on the 

NRC review questioning the reliability and uncertainty of the method, 

NIOSH determined that DTRA’s models could not bound the internal 

exposures with accuracy sufficient for this program. 

Dr. DeHart wondered, given the 65 case definitions and perhaps 1,000 

civilians involved, if there has been any active program to notify or 

contact prior workers. Dr. Neton did not know of any. 

***
 
PETITIONERS RESPONSE 

Ms. Daniella Karo, petitioner 

Ms. Karo indicated she had no presentation per se but, having read the 

evaluation, she did have questions to ask. She wanted to know how 

Congress came up with an upper limit of 250 days of exposure needed to 

establish this kind of class, why Amchitka Island employees were not 

held to this requirement, and what happens with individuals who were 

there for several weeks but less than 250 days. Dr. Ziemer mentioned 

that the episodic nature of testing at Pacific Proving Grounds might 

argue for a different approach than that used at a workplace where 

exposures were chronic; nonetheless, there is rationale for the 250 

related to other sites where that has been the criteria based on 

Congressional mandates. 

Dr. Neton said he could not speak to the legislatively-created SEC 

requirement of presence for Amchitka Island. Within NIOSH’s regulation 

the 250-day requirement covers almost chronic-based exposures rather 

than discrete health-endangering short term events. Although a nuclear 

detonation is arguably a criticality incident, these people were 

removed from the blast itself to exclusion zones and their exposures 

due to fallout from inhalation or resuspension are classified as 

chronic. That was the basis for NIOSH’s decision to apply the 250-day 

criteria. 

Ms. Karo repeated her concern about how individual petitions will be 

treated for claimants who did not meet the 250-day criteria and asked 
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why Amchitka Island was an exception. Dr. Neton said Amchitka Island 

was legislatively added by Congress and he did not know why they were 

excluded from the 250-day requirement. As with other SEC classes, if 

a claimant or case does not have 250 days aggregate exposure, there 

would still be an attempt to do dose reconstruction using other 

techniques deemed sufficiently accurate. In this case, NIOSH does not 

have a technique to do internal dose reconstruction to the required 

degree of accuracy. 

Ms. Karo inquired how NIOSH can proceed without the formula to figure 

out internal dose. Dr. Neton replied that NIOSH would reconstruct the 

external dose and if the persona did not meet the POC criteria based 

on external, the case would be denied. 

Mr. Griffon asked for a description of the nature of these employees’ 

work. Dr. Neton observed the range of activities was varied. Dr. Wade
 
clarified that the people considered for this class were removed from 

the blast but were exposed, through their work, to radiation for at 

least 250 days afterwards. 

*** 

Dr. Ziemer welcomed Dr. Paul Blake, program manager for the Nuclear 

Test Personnel Review (NTPR) program at DTRA, who offered an account 

of how the Department of Defense (DOD) currently conducts dose 

reconstructions with regard to the Pacific Proving Ground and its 

plans for the future. The Defense Threat Reduction Agency, a combat 

support agency of the DOD, functions as the executive agent for DOD 

supporting radiogenic disease claims brought forth by former DOD 

personnel who participated in atmospheric nuclear weapons testing from 

1945 through 1962 or served as U.S. occupation forces of Hiroshima and 

Nagasaki, or prisoners of war in those vicinities when the detonations 

occurred in 1945. DTRA supports the Department of Veterans Affairs 

and, to a lesser extent, the Department of Justice in evaluation of 

radiogenic disease claims. Since its inception in 1978, the NTPR 

program has accumulated a wealth of documentation associated with 

these nuclear events and developed methods for generating associated 

dose reconstructions. 

DTRA has been working to overcome the technical challenges of 

generating dose reconstructions for atomic veterans. These challenges 

are well documented in the 2003 National Academy of Sciences National 

Research Council report that Dr. Neton referenced earlier. One of the 

consequences of the NRC report was for the Department of Veterans 

Affairs to return to DTRA over 1,200 previously-generated dose 

reconstructions for reworking and correcting challenges noted in that 

report. 
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DTRA is concerned about timeliness of the work as many veterans are 

elderly and do not have many years to live. DTRA has made a decision 

to immediately address these concerns, modify procedures and begin 

releasing revised dose reconstructions while also publishing articles 

on the revised techniques on their public web site and in peer-review 

journals at an admittedly slower pace. This decision has led to the 

current situation in which NIOSH has determined it lacks sufficient 

information to estimate internal doses for Pacific proving Ground 

personnel while DTRA is currently in process of performing that very 

function. Dr. Blake expects the problems to be resolved by the end of 

calendar year 2006, when DTRA’s technical reports addressing the NRC 

2003 report will be published. 

Many of the internal dose challenges noted for the current site become 

even more challenging in context of the Nevada Test Site, specifically 

the scenario of the nuclear detonation blast wave resuspending 

radioactive fallout from previous detonations and complicating the 

determination of inhalation dose. Dr. Blake observed both NIOSH and 

this Board are in the difficult position of needing to make a timely 

decision, but caught in the dilemma of two federal agencies proposing 

two very different solutions, a challenge hopefully to be resolved by 

the end of calendar year 2006. 

*** 

BOARD DISCUSSION/RECOMMENDATION 

Discussion began with Dr. Ziemer asking if the 250-day requirement 

applies to DTRA dose reconstructions. Dr. Blake explained DTRA's 

requirements are of a much more episodic nature; a certain time period 

is defined for each atmospheric atomic test, and if a person was in 

that area at a certain period of time they qualify. DTRA’s 

requirements, mandated by Public Law and published in the Code of 

Federal Regulations, differ slightly as issued by two agencies, the 

Department of Veterans Affairs and Department of Justice. They can 

qualify someone for either presumptive or non-presumptive cancers, 

primarily prostate and skin cancer. Therefore, presence at even one 

test could rate consideration. Most of the 250,000 military personnel 

at Pacific Proving Ground and Nevada Test Site were part of the Navy 

sent there for weapons effects tests. The Atomic Energy Commission’s 

group under consideration by this Board was smaller. Dr. Ziemer and 

Dr. Blake’s discussion clarified that for military personnel who were 

closer to the detonations, external dose is the driver, whereas for 

the Atomic Energy Commission (AEC) personnel who were on the islands 

away from the blast, internal dose is more critical, yet data for 

these calculations are lacking. 
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Dr. Melius wondered if the Board’s group of concern might have some 

workers better addressed through the veterans program. Dr. Ziemer
 
thought that kind of specificity is lacking from the information 

database. Dr. DeHart asked how DTRA is handling dose reconstruction 

for military personnel or civilians who were in fact removed from the 

blast. Dr. Blake said internal dosimetry calculations are primarily 

based on radioactive fallout. Mr. Griffon asked about the interim 

rules of thumb guiding these calculations until the end of 2006 when 

resolution is expected. Dr. Blake replied that the preferable method 

is doing full uncertainty analysis as called for by the NRC report, 

but for expediency and due to large uncertainties DTRA is calculating 

a maximum radiation credible dose out to a 95 percent credibility 

limit and then forwarding them to the Department of Veterans Affairs 

to do the probability of causation calculation with similar software. 

NIOSH’s challenge arises from DTRA implementation of procedures not 

yet published. The conservative factor of ten mentioned in statements 

has a statistical basis and after looking at and bounding these 

concepts of fractionation, DTRA considers this a good figure. 

Dr. Wade commented that two federal agencies taking different 

positions can result from starting at different points and moving 

towards a common objective. He commended Dr. Blake and DTRA for their 

professionalism and commended the full vetting of issues in this 

debate. 

Dr. Ziemer emphasized the Board’s intent to give a full airing of the 

issues raised by differences between agencies and how things are 

calculated. He noted that even within the U.S. legal system, different 

laws can conflict so it’s not amiss that not all agencies are 

parallel. Everyone is working together but timeliness pushes the 

issues. Discussion focused on the possibility of a pre-publication 

sharing of information by DTRA to expedite NIOSH’s efforts. It would 

take time and possible perturbation of NIOSH’s process, and not all 

the consequences are foreseeable, but it is possible. During the 

exchange it was established that NIOSH lacks specifics on the workers’ 

living conditions, their only criteria to work with being little more 

than a case file, a job title in some instances, evidence of an 

external badge, and duration at the site. Dr. Blake detailed his 

interactions with his advisory board in preparation for their formal 

plan to be presented this summer in Austin, Texas. 

Dr. Melius had two comments. First, he felt the need for follow-up 

with claimants or survivors of Amchitka Island to gather information 

concerning how their 24-hour exposures were weighted; these workers 

were given an exemption from the 250-day rule because they lived 

there. Second, he understands the time limits but feels the dose 

reconstructions in these two programs may not be reconciled because of 
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different legislative mandates and methods. He cautioned against 

institutionalizing differences between the programs and their 

approaches simply out of not wanting to wait a few months to get the 

report. The results of the SEC petition decision will last a long time 

and it may turn out that some of the issues used as a basis for 

approving it may be addressed within the next few months. Consistency 

is desirable. He would feel much more comfortable waiting for clarity 

on some of these technical issues. Dr. Dehart also cautioned against 

potentially creating two different systems for the same kinds of 

exposure settings. Dr. Ziemer supported Mr. Espinosa’s suggestion of 

follow up with Amchitka Island workers to see if the 250-day issue 

might apply in a somewhat different way for them. 

Mr. Elliott commented for the Board’s consideration that at least 57 

claims remain to be dealt with, some from the first batch received in 

October, 2001, and these claimants await a decision. He also noted 

that of the three with dose reconstructions, one found to be 

compensable had multiple skin cancers and that was done using external 

dose. The other two were found to be non-compensable cancers from the 

presumptive list. 

Mr. Gibson pointed out the extensive listing of entertainment 

facilities at Enewetak Island which indicates workers were to stay 

there for extended time. Dr. Ziemer asked if there weren’t air samples 

giving an idea of the levels that people on the Marshall Islands were 

living with every day. Dr. Blake affirmed that radioactive fallout was 

measured fairly effectively using data from film badges, actual 

measured fallout in water, land and biological samples. Dr. Melius
 
reiterated his earlier concern, the issue of being badged or should 

have been badged, and possibly not qualifying people in the correct 

way for a Special Exposure Cohort. He felt a better and fairer job 

could be done using the scientific work underway for the veterans 

along with further work by NIOSH in describing this group of people in 

this cohort. 

Ms. Munn expressed concern that military and civilian personnel with 

the same work and exposures may be treated differently since internal 

dose cannot be assessed. She questioned whether the DTRA process will 

end up being applicable for this program, and emphasized that some 

claimants have already waited four years. Ensuing discussion revealed 

that during detonations at the Pacific Proving Grounds, both AEC and 

DOD personnel worked together as a joint task force such that the 

external dosimetry records are quite consistent; however, that still 

does not provide a solution for internal dosimetry. It may have been 

the case that the military personnel were more transient than those of 

the Atomic Energy Commission/Energy Research & Development 

Administration (AEC/ERDA.) Dr. Roessler expressed discomfort in 
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lacking enough information to vote now, but was less concerned than 

others about the difference in agency approaches because the more 

critical difference resides in the types of population and their 

exposures. Dr. Neton said despite joint efforts at monitoring, the 

dilemma of trying to reconstruct internal dose from reconstructed 

external data is compounded by lack of knowing the whereabouts of 

these civilians. 

Dr. Melius felt that it would be worthwhile for NIOSH to take the few 

months needed to see if DTRA’s developing information would address 

the main technical basis for SEC determination on the issue of 

internal monitoring. He preferred not voting on the petition now when 

these concerns may be addressed shortly. He suggested asking NIOSH to 

address the 250-day issue by the next meeting, taking care with this 

circumstance in terms of qualifying these people. 

A motion was made and seconded that the Board thank NIOSH for its 

report on the SEC petition and table further discussion to allow time 

for communication between NIOSH and DTRA and to address other issues 

previously stated by the Board.
 
Dr. Ziemer explained that a motion to table is not debatable. A yes 

vote to table will force resolution at the next face-to-face Board 

meeting in April. Those wishing not to table can vote no and an 

alternate motion could be made. However, a proposed action must first 

be made which could then be tabled. Dr. Neton pointed out that NIOSH 

is unlikely to have a detailed plan ready for the April meeting. Mr. 

Gibson expressed concern about the 180-day limit and wondered if 

waiting would gain anything. 

A motion was made and seconded to accept the petition as presented. 

Dr. Ziemer explained the motion to accept the petition is a motion to 

accept the recommendation of NIOSH to grant the SEC petition, and if 

it passed it would be a recommendation to the Secretary of Health and 

Human Services that SEC status be granted. Debate ensued. 

Ms. Munn said if we can make the assumption that resuspension and 

internal dosimetry for individuals on those islands would vary from 

location to location on the islands, she believes it will be 

impossible to come to an acceptable conclusion on internal dose. Dr. 

Melius and Dr. Neton clarified that the uncertainty associated with 

the resuspension factor arises more from ships versus the island 

rather than from worker location within the islands; even so, if that 

is a basis for an SEC, that point needs to be captured specifically 

within the Board’s recommendation. 
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Dr. Wade, Dr. Ziemer and Dr. Blake discussed what NIOSH and DTRA could 

do before the end of April that would shed light on the issue of 

internal exposure. With technical work still in development there is 

no guarantee of what the end product will look like or whether the 

work available in time for April will inform NIOSH’s efforts, even 

though Dr. Blake believes he is authorized to share such information. 

A motion to table the motion under consideration was made and 

seconded.
 
The vote was five yes to four no with one abstention. Tabling would 

require a majority of those voting, but the abstention is not ignored. 

Six votes are needed to carry the motion. Mr. Presley spoke to change 

his vote. 

Upon the second round of voting, six yes votes carried the motion. The 

vote is to table the action until the next meeting, and it is so 

ordered. 

*** 

Having tabled the action on Pacific Proving Ground, Dr. Ziemer said 

the Board would need to provide instructions for its expectations 

within the coming week. Dr. Ziemer and Ms. Liz Homoki-Titus of HHS 

established that if another department provides information to HHS 

that is not available publicly, its degree of potential usefulness 

could be summarized by Dr. Neton or his designee without necessarily 

releasing classified information. If such information comes fully to 

the Board, however, it will be made public. 

A motion was made and seconded to request that NIOSH follow up on 

three items in relation to this petition: 

#1 to gather further information and evaluate DTRA’s technical work 

on addressing monitoring and evaluation of internal dose; 

#2 to conduct further evaluation of the types of work and nature of 

exposures for people in different work categories, including 

clarification regarding residence; 

#3 to determine how best to address this issue of qualification for 

the cohort, i.e. monitored or should have been monitored, and possible 

adjustment of the 250-day requirement for full time residents. 

Debate ensued. Dr. Melius wanted to word part three so as to ensure 

that this requirement makes it applicable for all the categories of 
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workers who might be considered for inclusion in a Special Exposure 

Cohort. Dr. Ziemer asked if monitoring for 24 hour resident workers 

differed from that of badged workers who left their badge at the gate 

when leaving a facility, and Mr. Presley said the badge was worn 

everywhere on site, 24 hours a day. Mr. Espinosa spoke in favor of the 

motion, his greatest concern being that many under the class would be 

denied on the basis of 250 days. 

Mr. Gibson spoke in favor and offered a friendly amendment that a 

member of the Board with clearance be present during discussions 

between NIOSH and DTRA. 

The mover and seconder accepted the friendly amendment and it was 

agreed that item one of the motion would include the caveat that this 

be done with Board member or members present. 

The motion passed without opposition, with one abstention. 

Ms. Karo was thanked and left the conversation. 

***** 

 CLASSIFIED DATA: 

IMPACT ON BOARD SEC PETITION RECOMMENDATION 

Dr. Lewis Wade, 

Executive Secretary/Designated Federal Official 

Dr. Wade addressed this item as a result of the Board’s questions 

about due process considerations. He met with representatives of both 

the Secretary’s office and the HHS Office of General Council. The HHS 

position, based on a verbal opinion from the Department of Justice, 

concludes that non-disclosure to the public of classified information 

does not qualify a class for addition to the SEC if a sufficiently 

accurate dose reconstruction is otherwise feasible using restricted 

information. Therefore, HHS has no legal authority to grant a Special 

Exposure Cohort petition because classified or restricted information 

was used to determine that a sufficiently accurate dose reconstruction 

can be done. The Department of Justice holds that access by claimants 

or the public to classified information on which HHS may rely in 

making a feasibility determination is not required by due process 

considerations. Mr. Gibson wanted to know why the office of Legal 

Counsel is resistant to put it in writing. Dr. Wade could not answer 

that question but he did offer go back and ask again to get it in 

writing if the Board wishes. His main concern was that the Board be 

not limited in its ability to do its business. Dr. Melius argued this 

does disenfranchise the Board wherever there is classified or 
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restricted information, precluding the Board from evaluating NIOSH’s 

review of the SEC petition. Ms. Homoki-Titus clarified that this 

simply limits public access to classified information; EEOICPA gives 

the Department of Energy authority to provide a grant of access to 

sensitive compartmented information (Q clearances) for Board members. 

Due to the high proportion of Board members with conflicts of 

interest, it was felt that the Board would benefit from having a much 

larger number of Q clearances. 

Dr. Ziemer asked that Mr. Gibson and Dr. Melius draft a proposed 

motion and letter for the Board to act on tomorrow regarding its need 

for an increased number of Q-clearances. 

***** 

BOARD CORRESPONDENCE RESPONSE TO LETTERS FROM SENATOR CLINTON, SENATOR 

SCHUMER, REPRESENTATIVE HIGGINS, REPRESENTATIVE SLAUGHTER, 

AND MIKE WRIGHT, STEEL WORKERS 

Regarding Congressional correspondence, Dr. Ziemer drafted some 

responses according to Board rules. Board members have copies of the 

draft response to Senator Clinton’s November 7th letter concerning 

Bethlehem Steel. 

A motion was made and seconded to accept the draft, along with 

proposed amendments using NIOSH’s updated figures. Discussion included 

modification of wording, after which the motion to transmit the letter 

carried unanimously. 

*** 

A motion was made and seconded to transmit Dr. Ziemer’s response to 

Senator Schumer’s November 14th letter. Discussion resulted in 

modification of wording in the same manner as in the Clinton letter. 

The motion passed unanimously.

Dr. Ziemer will re-draft a response to Senator Schumer’s January 19th 

letter requesting the Board to rescind its action of January 9. The 

new letter to be emailed to the Board will clarify that NIOSH’s 

actions will come back to the Board in the revised site profile which 

will include more recent information such as issues raised by Mr. Ed 

Walker, the seeming omission of which is the basis for Senator 

Schumer’s request to rescind. 
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The Board agreed without objection to look at the e-mail draft, 

transmit as-is if there are no wording issues or delay transmission if 

re-wording is needed. 

It was decided that no action is needed on the letters from 

Congresswoman Slaughter and Congressman Higgins, as these written 

statements were already read into the record. Dr. Wade concurred. The 

Hanford letter will be covered during the Hanford agenda item. 

*** 

WORKER INTERACTIONS 

Presentation by NIOSH/ORAU 

In preparation for the letter from Mike Wright of the steelworkers' 

union, Ms. Kate Kimpan, project director for the ORAU team for this 

effort, presented a briefing on efforts with regard to collecting and 

taking into account worker information. 

Mr. Wright’s letter to the Board exemplifies a growing need felt by 

both ORAU and NIOSH to respond to information and comments. At ORAU’s 

ongoing worker outreach meetings a NIOSH representative and the site 

profile’s team leader are always present, dedicated to taking 

immediate action. ORAU and OCAS have developed the Worker Input to 

Site Profile Revisions (WISPR) database which captures all comments 

and assures that the commenter and public understand the team’s 

response. Ms. Kimpan acknowledged there is room for improvement in 

coordinating the responses and conveying the value of those comments 

to those making them. Commenters need to know they are being heard and 

what is being done with the information. It’s easiest to convey 

feedback to unions and on the web, but other methods are needed to 

reach individuals who may not have internet access or belong to a 

unified group. Ms. Kimpan welcomed all suggestions for improvement. 

For the record, this relates to ORAU Procedure 0097, Revision 00, 

AConduct of the Worker Outreach Program,@ approved on December 29, 
2005. 
Dr. Ziemer requested some more formal means by which the Board could 

track the wealth of information emerging from the public comment 

periods. ORAU’s Top Hat database had captured relevant information 

from transcripts but the Agency for Toxic Substances and Disease 

Registry (ATSDR)’s software package was unusable outside of ORAU. That 

information has been transferred to WISPR. Dr. Ziemer acknowledged 

that follow-up is occurring but felt a formalized process would 
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prevent comments from falling through the cracks. Mr. Elliott said 

that much of what they hear is not ultimately relevant but the people 

making comment need feedback on why it was not useful. Plans are 

underway to give SC&A access to the WISPR database. Mr. Elliott said 

written comments get a written response; verbal comments during worker 

outreach meetings are captured in the minutes and posted on the web; 

but people making comment need to be notified, appreciated, and told 

why the comments may not be relevant for dose reconstruction purposes. 

Another source of input is town hall meetings, which will be held 

again this summer; Mr. Elliott wanted that to go on record. The WISPR 

database does have comment and resolution; in fact, resolution is 

essential before an item can be closed out. Dr. Wade offered to make 

sure the SC&A task to review procedures is modified to include 0097 

Rev. and at the request of Ms. Kimpan he will also add Revised Proc. 

0031, the TBD which has been revised to accommodate these other 

changes. Dr. Wade will ask that the WISPR database be made available 

to the Board and SC&A and that the Board by emailed when availability 

is granted. Comments from this meeting should be reviewed thoroughly 

and entered in to the WISPR database. Dr. Melius questioned lack of 

response on comments made two years ago by union representative Mr. 

Glenn Bell. Mr. Elliott said Mr. Bell’s submission included maps of 

the site and other information which an ORAU classification officer 

must review before it goes on their web site. It is under review. Dr. 

Melius emphasized the need for a formalized process to address the 

increasing frustration from people who sense that their comments are 

ignored or largely discounted. People at the sites need reassurances 

that significant changes will not be made without an opportunity for 

their input. Mr. Elliott and Ms. Kimpan agreed on the pressing need to 

assure people but they asserted that the comments are indeed taken 

extremely seriously and have resulted in many changes to actual 

operations for thousands of dose reconstructions. Ms. Kimpan will 

provide to the Board and the public her lengthy list of comments that 

have resulted in changes. 

It was agreed Dr. Ziemer will send a formal reply to Michael Wright at 

the United Steelworkers’ summarizing ORAU's efforts toward formal 

tracking of comments and follow up. 

***** 

ROCKY FLATS SITE PROFILE 

DISCUSSION/PLAN OF ACTION 

Discussion of the Rocky Flats site profile matrix included remote 

participants Tony DeMaiori of the United Steelworkers and staff of the 

Colorado Congressional delegation: David Hiller from Senator Salazar’s 
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office, Jeanette Alberg with Senator Allard’s office, Carolyn Boller
 
from Congressman Udall’s office and Amy Warder with Congressman 

Beauprez.

SITE PROFILE REVIEW 

Mr. Joe Fitzgerald, 

Sanford Cohen & Associates 

The site profile review consisted of highlights of the December 15 

matrix focusing on issues significant from a dose reconstruction 

standpoint. NIOSH will detail its preliminary responses to each of the 

21 findings later, although these have not yet been discussed in the 

working group. 

#1 The primary issue is that the use of urine bioassay MDA median 

values may not be appropriate for plutonium and americium, due to 

primitive internal bioassay techniques in the 1950’s and early 1960’s. 

They are unduly low and likely to underestimate internal dose. SC&A 

asks NIOSH to revisit the parameters and come up with more 

appropriately conservative Minimum Detectable Activity (MDAs), perhaps 

taking two of the four parameters and using the more extreme values to 

come up with higher MDA values. 

#2 Another primary issue says the TBD approach to low or insoluble 

plutonium compounds needs review, due to the question of acute intakes 

of such compounds and whether or not this might be a significant 

contributor in certain target organs such as the GI tract. A claimant 

favorable approach will depend on the type of concern, per ORAUT-PROC­
0003, which is not referenced in this TBD. 

#3 A third primary issue addressed by SC&A is the inadequacies in 

neutron exposure characterization: how to extend correction factors 

beyond the nuclear track emulsion-type A (NTA) film energies below the 

700 and 800 keV threshold and to apply such correction factors to 

other workers. The NTA film study focused on workers in plutonium 

operations. It did not include non-plutonium operations or workers 

possibly exposed to specific neutron sources beyond those production 

facilities. SC&A wants to identify correction factors that are broadly 

applied for neutron exposures across the Rocky Flats operations. NIOSH 

is working diligently to get University of Colorado’s job-specific 

neutron exposure data. 

#4 SC&A is also concerned about other issues, including addressing 

potential data reliability concerns; potential problems with 

algorithms and dosimeter calibrations; the placement of dosimeters in 
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relation to aprons; dosimeters not worn or not properly worn; 
assignment of Azero@ doses at a time when everybody had a combination 
security/dosimetry badge. Suitable explanations for these issues are 
needed now to assure reliability of the data. Mr. Fitzgerald paused to 
take any questions. 
In answer to Mr. Hiller’s query about impact of unanswered questions 

if these issues cannot be answered satisfactorily, NIOSH would have to 

address that issue as a gap in the database and weigh the implications 

on the reliability of the overall data. Tony DeMaiori said the term 

Ano current data available@ was historically used at Rocky Flats for 
unexplained dose, even a high one. Mr. Fitzgerald said SC&A would be 
concerned about that and in fact such reports appear in the 
documentation from coworkers. SC&A has recommended that NIOSH look 
into it further. 
More minor issues include concerns over the assumed default particle 

size of 5 micron AMAD; uncertainties not addressed for americium 241 

material assay and how lung counting was calibrated with these values; 

the non-claimant-favorable assumption of full equilibrium in 

methodologies to assess internal exposure to depleted uranium; the 

assignment of isotropic and rotational instead of anterior-posterior 

geometry which may not fit some Rocky Flats workplace exposure 

circumstances; inadequate consideration of contaminant radionuclides 

present from uranium and other radionuclides shipped or processed 

onsite, particularly U-233 with the U-232. 

Mr. Fitzgerald again paused for questions. 

Dr. Ziemer pointed out to the Colorado delegation that exchanges 

between SC&A and NIOSH have been taking place over the past two or 

three months to address these issues. The Board will extend an 

invitation to a representative of the petitioners to take part in the 

face-to-face meetings. Of the six chapters in the site profile each 

has its own revision number; some are at Revision 1 and most are still 

Revision 0 in an ongoing process of updating the site profile as new 

information is gained. 

*** 

In the Board questions and comments period, Dr. Wade expressed his 

desire to have the Board presented with an evaluation plan before the 

April meeting and have the Board make a recommendation to the 

Secretary on Rocky Flats. 

*** 
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NIOSH RESPONSE 

Dr. Jim Neton, 

NIOSH 

NIOSH’s draft responses to the 21 individual issues identified in the 

consolidated matrix issued in mid-December were covered in detail 

yesterday. Copies of the matrix are on the table. Dr. Neton’s main 

message is that the consolidated matrix and all NIOSH efforts now will 

be directed towards resolving issues of specific relevance to the SEC 

petition at hand. Dr. Neton commended Mr. Fitzgerald’s summary of the 

five key issues. Regarding the first two, the MDA issue and the super 

insoluble material, NIOSH has already come a long way towards coming 

to terms with SC&A and he looks forward to working with them and 

addressing the other issues in the upcoming working group meetings. 

*** 

Discussion Topics:
 
#The importance of keeping Mr. DeMaiori and his people actively 
involved in the process. 
#Clarification on finding number two on the matrix, where Type S and 
Type M are compared without reference to super S class. 
#In the analysis, super S had been determined to be synonymous with 
S. 
#The doses to the lung are adequately covered by S because they’re 
already more than likely over 50 percent. 
#Is there a coworker model for the claimants in the SEC petition 
class and what percentage of the class might this affect. 
#NIOSH does not typically include coworker models in the site 
profiles. 
#Progress made toward exploring ways to validate the data. 
#NIOSH is working towards that with ORAU, recognizing this will be a 
recurring issue. 
#Whether a recommendation on the SEC petition will be ready for the 
Board’s April meeting. 
#NIOSH is working towards the pedigree of the data, providing an 
approach to dealing with ancillary nuclides, and example dose 
reconstructions. 
#The reliability issue is essential because if that issue cannot be 
addressed then the other ones are not relevant. 
#Is matrix issue nine on questions of reliability and validity of 
data critical in terms of the accuracy of the radiation dose. 
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#It is, but NIOSH is revising its response to comment number nine, as 
they had mistakenly addressed an internal rather than external 
dosimetry issue. 
#The Colorado delegation is focused on that issue, and believes if 
there is insufficient information to determine the dose to this 
class, the petition must be resolved immediately. 
#Premature review of an SEC petition only increases tension, wastes 
time and detracts from credibility of both the SEC process and 
overall program. 
*****
 
The working groups for upcoming projects were self-selected. Mr. 

Griffon raised the concern that the current working group is becoming 

a standing committee, but he acknowledged that the tasks do change, so 

it was decided Mr. Griffon, Mr. Presley, Mr. Gibson and Ms. Munn could 

continue at least through Rocky Flats to function as a workgroup and 

coordinate with NIOSH and SC&A. Tony DeMaiori with United Steel 

Workers (USW) will represent the petitioners. For the record, Colorado 

delegates asked for notification of when the working group meets, and 

Dr. Ziemer agreed it will be done. 

*****
 
Ms. Livia Lam, legislative assistant for Senator Cantwell, joined the 

meeting by telephone for discussion of the Hanford site profile. Dr. 

Wade reported that the only Board member conflicted on Hanford is Ms. 

Munn. She was instructed and agreed that she may participate in the 

table discussion but cannot make or vote on motions. 

HANFORD SITE PROFILE B PRESENTATION 
HANFORD SITE PROFILE REVIEW 

Dr. John Mauro, 

Sanford Cohen & Associates 

Dr. Mauro presented the Hanford site profile review using an issues-

tracking matrix as requested by the Board. Eleven issues were 

summarized and submitted January 16 of 2006. 

#1 The major concerns have to do with neutron doses, especially in 

the early years, and exposures to exotic radionuclides. Neutron doses 

were calculated using the neutron-to-photon ratio gleaned from seven 

workers who had both neutron detector film (NTA film) and regular film 
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badges. Given the complexity and size of the site, the first question 

here is whether or not a seven-worker basis is good enough. 

#2 Secondly, because NIOSH had been concerned that the NTA film 

itself was not a good detector, presumably catching only 28 percent of 

the exposure, they used a multiplier of 3.57. SC&A questions that 

adjustment factor, because the vast majority of neutrons leaving the 

reactor were below .7 MeV and would not register, and of the larger 

0.3 particles needed to register, most would not score a direct hit to 

the badge. SC&A also takes issue with NIOSH’s seven-fold reduction of 

that same neutron-to-photo ratio in the N reactor because it was based 

on an unsubstantiated assumption that shielding had been installed. 

#3 SC&A challenges NIOSH’s application of post-1972 data from the 

186 Hanford Multi-Purpose Dosimeters (HMPD) to prior operations 

because pre-1972 there were more hands-on operations, and NIOSH’s 

assumptions do not adjust for design and operational changes that 

occurred. Also, NIOSH used a dataset with measured values above 20 

millirem even though the minimum detectable limit was 50 millirem. 

On the issue of neutrons, Dr. Ziemer asked if Hanford didn’t have 

spectral data. Dr. Behling said that is explained in SC&A’s TBD 

review. The 28 percent or 3.52 correction factor for NTA film used a 

tissue equivalent proportional counter rather than a spectral 

analysis. 

Dr. Neton pointed out regarding neutrons that the issue of sodium 24 

doesn’t necessarily mean it was an activation product in the body. 

There was sodium 24 in the drinking water. Regarding detection 

limits, he said they were generating distributions. In generating a 

lognormal distribution, the detection limit is not relevant as long as 

one is rank ordering doing cumulative probability plots. You can still 

pick off the 50th percentile in the geometric standard of deviation. 

Dr. Ziemer was struck, he said, by the implication that they had no 

spectral information because he knows some of those HPs who were there 

in the early days and he was certain it existed. Dr. Behling
 
commented on the paradox of saying NTA film was not reliable to 

monitor people but it’s regarded as good enough to measure neutron-to­
photon ratios. 

Dr. Mauro continued the Rocky Flats site profile review with an 

overview of the issues related to internal dose. SC&A questions 

whether the default values capture the full distribution of recycled 

uranium and trace levels of plutonium, americium and neptunium in a 

way that accounts for all the uncertainties. Prior to 1988 the 

bioassay data is not great for getting a full appreciation of intakes 

of these radionuclides. Also, the supporting literature indicates 
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there was much experimental work or special campaigns involving 

fissile material uranium-233 and its associated uranium-232, as well 

as large quantities of cobalt-60, carbon-14, yttrium and polonium-210. 

SC&A is not convinced that the TBD addresses the rich mix of 

radionuclides and the associated uncertainties. Without bioassay data, 

surrogate approaches must be used, so how well do the instructions for 

dose reconstructors hold up. The TBD covers three different time 

periods, and Dr. Mauro opined NIOSH has used a pretty conservative set 

of assumptions; however, how reliable was the judgment of those taking 

air samples, considering that the full of array of radionuclides was 

not disclosed. Can this incredible gap for internal exposure be 

filled by a one size fits all measure. 

Regarding lesser issues, ambiguity on instructions for interpretation 

of film badge data may have already been solved by use of the 

workbooks. Little attention was given to extremity dose. SC&A feels 

there is room for improvement on bounding the environmental exposure, 

noting that even though NIOSH used the RATCHET computer program, they 

did not use its puff invection modeling feature. More discussion is 

needed regarding exposures associated with tank farms, especially 

during the extensive D & D operations, along with better guidance for 

dose reconstructors on exposures particularly with regard to 

incidents. Ms. Munn commented on Dr. Mauro’s refinement of the issues 

to a manageable size and the in-depth record-keeping continuum at the 

Hanford site providing a depth of information not available at all 

other sites. Dr. Ziemer spoke to assure that copies of this report 

will be made available. 

*** 

HANFORD SITE PROFILE /PLAN OF ACTION 

Discussion followed regarding timeline targets for resolution on the 

work at hand. 

It was decided that SC&A and NIOSH will engage in a technical 

discussion to which a Board member would also be invited, with SC&A to 

provide its transcript and summary to the Board, followed by rough 

draft responses from NIOSH available for further discussion. 

***** 

Dr. Ziemer requested reversal of two agenda items so the Board can 

hear the SC&A report before holding discussion on its own SEC 

procedures involving the recently developed Task Five which allows 

SC&A to assist the Board in various aspects of Special Exposure Cohort 

reviews. SC&A will be asked to review the procedures used by NIOSH and 

36
 
   
 
 
 
 
 
 
 
 
 
 
 
           Summary Minutes January 24-26, 2006 

NIOSH/CDC Advisory Board on Radiation and Worker Health 

its contractor, ORAU, on the SEC evaluation process. Subtask two asks 

the contractor to provide its thoughts on how the Board itself should 

proceed in handling SEC petitions. The working group has 

simultaneously developed some criteria for evaluating SEC petitions. 

REPORT FROM SC&A ON SEC TASK 

Subtask one 

Dr. Arjun Makhijani, 

Sanford Cohen & Associates
 
Dr. Makhijani gave a presentation on both the subtask one and two 

findings of the Board’s contractor. They looked at the rule, 42 CFR 83 

and the main procedures in OCAS PR-004 and reviewed the forms A and B 

which prospective petitioners would use to file the petitions, along 

with OCAS IG-001 and 2, external and internal dose procedures for use 

in SEC petition evaluation. 

Noted strengths include NIOSH’s logical step by step procedures 

allowing NIOSH to divide the proposed class into sub-classes, useful 

examples for early designation of a certain sub-class and dose 

reconstruction for non-SEC cancers. 

Regarding findings, the NIOSH procedures lack detailed guidance on how 

to calculate maximum dose-- that is, they lack definition of criteria 

where maximum doses might be considered reasonable so that maximum 

doses do not become arbitrary, and guidelines are needed for job 

categories, evaluating data integrity, and for conducting a 

scientifically reliable maximum dose estimation for unmonitored 

workers. 

One of the most important and difficult points arose from conflicted 

rules for maximum dose calculations. Maximum dose under 42 CFR 83 

methods could be used to compensate as well as deny, so that should 

not end up being higher than the highest worst-case assumption that 

will involve no uncertainty under 42 CFR 82. To clarify this problem, 

SC&A suggests that an uncertainty which requires that the worst-case 

dose under 42 CFR 82 always be higher than the maximum dose under 42 

CFR 83. NIOSH does have provision for working extensively with 

petitioners but SC&A feels that survivors who are not claimants but 

who may want to become petitioners need special assistance in terms of 

incidents, working conditions, explanation of site profiles and the 

like. There is post-petition assistance but more pre-petition help is 

needed. SC&A also recommends that a detailed interview with at least 

one of the petitioners be part of the guidelines, so as to obviate 

misunderstandings if an SEC petition is denied and to provide NIOSH 

with greater clarity as to the petitioners’ concerns. The guidelines 
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could use some examples to clarify the basis for sufficiently accurate 

dose estimation. This advice is offered without criticism and with 

recognition of the benefit of hindsight. The final issue relates to 

health endangerment. The example in the rule and guidelines concerns 

external criticality accidents but there is no corresponding example 

for internal dose. Neither is there one for how to proceed for people 

who worked less than 250 days. That completed the review of the 

guidelines. 

*** 

In the discussion that followed, Dr. Neton offered clarification on 

what he perceives as an ongoing misunderstanding about maximum dose 

used to compensate or deny. 42 CFR 83 establishes the fact of the need 

to establish a maximum dose with plausible assumptions in order to 

deny a class. However, if the class were denied, that maximum dose 

would not necessarily be used to do dose reconstructions under 42 CFR 

82; it would just be a bounding, plausible analysis to demonstrate 

ability to put some plausible upper limit. If a more refined method 

becomes available, a better estimate can be used. Without additional 

information, the maximum plausible dose used to deny the class could 

become the best estimate. At that point it is no longer a maximum 

dose. The maximum plausible dose for SEC petition and analysis is very 

different than the maximum dose used in the efficiency process to deny 

cases. Dr. Makhijani replied that the point of this finding is that 

whatever the terminology, a certain plausible dose method was 

developed as was the case of Mallinckrodt, and if that had been denied 

and no further information was available, doses would then have been 

calculated by that method to compensate or deny people, depending on 

POC. SC&A maintains that doses being used to deny people should be 

less than doses used to compensate people. There should be some 

restriction in going from the SEC rule after denial as to how those 

cases are handled, even recognizing the distinction in terms. Dr. 

Neton then conceded the point and agreed that if cases are denied 

based on maximum plausible, there should not be a higher maximum 

plausible for SEC. Dr. Ziemer said it is really a terminology issue. 

Dr. Wade highlighted the value of Dr. Makhijani’s point as it relates 

to the Board’s ability to communicate consistently with people. 

Dr. Melius thinks clarification on the issue of the 250 days will come 

out of work on the Pacific Proving Grounds. He asked for comment on 

the last point, lack of procedures on determining the breadth of the 

class when NIOSH finds that it cannot reconstruct a claimant’s dose. 

Dr. Neton agreed about the lack of such a procedure but said this is 

driven by the availability of the data, which speaks for itself. He 

said he could not envision how to proceduralize that. Discussion 

followed on how classes and sub-classes are intuited by sifting 
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through data and created through the petition process, the issue being 

how to recognize the right subsets to define the class and whether for 

efficiency that can be codified in some way. Dr. Neton thought that 

the working group’s draft guidelines may help with that because they 

look not only at what and who was monitored but also what was not 

monitored. The addition of ancillary nuclides of exposure may result 

in definition of a class by nuclide type. Careful evaluation of data 

can spare the need for later re-working. Dr. Wade suggested inviting 

colleagues from the DOL who are left to make these decisions on the 

recommendations. This is an evolving process. 

***** 

Subtask two 

Dr. Makhijani’s report on subtask two contains three phases suggested 

for SC&A’s own procedures. The preliminary step for Phase one, to be 

taken immediately after NIOSH qualifies a petition for evaluation, 

calls for NIOSH to submit an implicit evaluation plan so the review 

can be done serially by NIOSH and the Board. Phase two, during the 

time NIOSH is evaluating the petition, suggests compressing the 

procedure by having NIOSH provide example dose reconstructions 

illustrating the issues relevant to feasibility so that both NIOSH and 

the Board could arrive at a conclusion as to feasibility. After NIOSH 

has submitted an evaluation for the Board’s consideration, Phase three 

is already in place. As delineated in 42 CFR 83, NIOSH and 

petitioners and all other points of view are considered for a decision 

on either further review or action. SC&A also suggests draft 

procedures by which the Board contractor can review the petition and 

associated documents and determine what kinds of partial dose 

reconstructions would be needed in order to clarify issues on 

feasibility of dose reconstruction. Here are their proposals for 

various scenarios. 

1 When there is no site profile review, they would do a targeted 

review of the site profile only for issues relevant to maximum dose 

reconstructions. 

2 When there is no site profile, SC&A would perform a focused 

review of the conditions at the site including such factors as 

radionuclides and job types to target what is relevant for maximum 

dose reconstruction under plausible assumptions for that site. 

3 Partial reviews would follow steps like the ones described for 

phase two of the Board procedure. 
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Dr. Wade added that part of the task put in place with SC&A allows for 

the Board to ask for SC&A’s assistance in a petition evaluation 

review, whether it be a full or task-specific review. 

During the comments, Dr. Melius said he’d prefer to use the term 

targeted rather than partial. He suggested that after reviewing the 

materials, NIOSH could prepare a more specific plan for what they 

regarded as the critical datasets, particularly regarding the SEC 

evaluation, to be discussed at a meeting with NIOSH, a workgroup and 

the contractor. This approach would be parallel rather than serial. 

Dr. Ziemer, Mr. Griffon and Dr. Melius brought forth that this is 

already happening to some extent, but the current terms such as 

partial, full, and targeted can be confusing in context of the SEC 

review. Mr. Elliott acknowledged that the plan given today and on 

every evaluation of a petition is intentionally generic and hopefully 

comprehensive in its generality. It’s a struggle within the 180 day 

time frame to provide a scientific basis for making a recommendation 

to add or deny a class. Rather than provide a make-work, additional 

detailed plan, he can see better benefit in a coordinated effort 

involving NIOSH, the working group and SC&A, meeting to discuss the 

salient issues for evaluating a petition. Dr. Mauro noted that the 

closeout process, for which his team allocates 150 hours, has now 

become part of the much more demanding SEC process. Dr. Makhijani
 
supported the need for more site-specific information from NIOSH, 

particularly on dose reconstructions for SECS in conjunction with site 

profile reviews. Feasibility under SEC requires that the methods be 

actually applicable in real dose reconstructions. The other big 

difference is that in site profile reviews, vertical issues are 

highlighted but not covered in detail, whereas for the SEC petition 

review, every detail on feasibility must be covered for the answer on 

all cancers and all members of the class. He feels there is great 

merit in having something focused on SEC reviews. 

Mr. Griffon echoed the spirit of the intent to have earlier 

involvement with the Board and SC&A rather than a detailed plan which 

could become obsolete within the 180-day limit. Dr. Makhijani made 

assurances there is no bureaucratic intent in their proposal. Dr. 

Melius said NIOSH does have access to information that is available to 

no one else -- completed dose reconstructions for a particular site, 

which would be helpful in developing a more focused plan earlier in 

the process. Mr. Elliott agreed on the benefit of that. NIOSH is 

taking seriously the Board’s need to see example dose reconstructions 

if NIOSH is saying to deny the class. Dr. Wade said the discussion has 

been useful and he thinks the spirit of Mr. Elliott’s suggestion is 

the same as those presented by Dr. Makhijani. To facilitate the 

process of earlier interaction, he pointed out the Board’s opportunity 

now to choose one site to use as a first example of trying to put this 
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process in place, as the current targets of opportunity are limited. 

From the standpoint of limited resources, Mr. Elliott asked the record 

to show which site petitions are currently being evaluated. They are 

the Pacific Proving Ground, the Rocky Flats petition, Chapman Valve, 

the Oak Ridge Institute for Nuclear Studies -- almost all of the ORAU 

folks are conflicted there so his group is doing that, which presents 

yet another resource-limiting problem -- and Ames, Iowa. Dr. Ziemer
 
suggested completing the framework for that decision today and then 

making a specific site choice tomorrow. 

***** 

PROCEDURES FOR BOARD EVALUATION OF SEC PETITIONS 

DISCUSSION PART II 

(including pending Y-12 Petition and SC&A SEC Task) 

Concerning the item called procedures for Board evaluation of SEC 

petitions, Dr. Ziemer felt this was the time to identify any 

substantive changes to the document. Dr. Wade reminded the Board that 

the Secretary wants full vetting of the document along with the 

opportunity to comment on the procedures before they are finalized by 

the Board. Dr. Melius began the discussion listing issues raised 

yesterday: feasibility, timeliness, regulations, and use of data from 

other sites for a site profile. Ms. Homoki-Titus could not at this 

point give a legal interpretation of timeliness, but she read a 

portion of the actual statute which uses the term and cited the two 

new deadlines that have been added, the 180 days to make a 

recommendation and 30 days for the President to provide a 

determination to Congress, once this Board provides a positive 

determination to the Secretary. She also stated that the current and 

recommended SEC rule gives the Director of OCAS the ability to 

determine that records are not available in the timely manner. Ms. 

Munn spoke for accepting the document as is, explaining that 

specificity will reduce both fluidity and timeliness of the process. 

She offered to move it. Dr. Melius first wanted to come up with 

criteria for how to use data from other sites. Dr. Ziemer suggested 

accepting the document provisionally, soliciting input from the 

Secretary’s office and having a caveat that it’s open to additional 

amendments as the Board sees fit. 

A motion was made and seconded that the Board accept the document 

before it as a provisional document, with the understanding that the 

input of the Secretary's office will be used to help expand the 

document and complete it. The motion carried unanimously. 
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***** 

PUBLIC COMMENT 

Dr. Ziemer greeted attendees for the Public Comment period and 

explained what the Board does and does not do. 

The following is a list of the members of the public who spoke. A full 

transcript of the public comment is available on the OCAS web site, 

www.cdc.gov/niosh/ocas.
 
Mr. Jim Phelps, son of Y-12 employee; Mr. T. L. Dishman, retired Y-12 

employee; Mr. Ray Beatty, Fernald employee; Ms. Johnnie Sue Goodman, 

survivor wife; Ms. Helen (last name not given), survivor wife; Mr. 

Franklin Tucker, retired Y-12 employee; Ms. Dorothy Thompson, Y-12 

widow; Mr. Thomas Duncan, claimant; Mr. Paul Royster, son of Y-12 

employee; Ms. Florene Robertson, X-10 widow; Ms. Gail Burgess, 

survivor daughter; Ms. Sharon Slackey, survivor daughter; Ms. Kathy 

Miller, survivor daughter; Ms. Faye Holt, survivor wife; Ms. Lindsay 

Long, claimant; Mr. Earl O'Neal, former Y-12 employee; Ms. Diane 

Boinet, survivor sister; Ms. Shirley Moody, Y-12 widow; Mr. Dennis 

Brown, K-25 survivor ;Ms. Diane McKeethan, claimant; Mr. Frank Scott, 

Y-12 employee; Ms. Valerie Maner, daughter of Y-12 employee; Ms. Ellen 

Foster, claimant's daughter; Ms. Janice Allen, claimant's daughter; 

Mr. M. L. Russell, claimant; Mr. Otis Lee, retired DOE employee; Ms. 

Debra Kiley, survivor daughter; Mr. Martin Delozier, claimant's son; 

Mr. James Hackworth, brother of former Y-12 employee; Mr. Leonard 

Bowers, retired Y-12 employee. 

With no further comments, the Board officially recessed until the 

following morning. 

Thursday, January 26, 2006
 
Dr. Ziemer opened the third day of sessions on the Advisory Board on 

Radiation and Worker Health, reminding all to register attendance and 

pick up a copy of the agenda and related documents. Mr. Elliott read 

a written statement into the record on behalf of Ms. Beulah J. Lindsey 

and her brother Alvin, who could not stay for last night’s public 

comment session. That statement appears in the transcript of the 

meeting available on the OCAS web site, www.cdc.gov/niosh/ocas. 

*****
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In his conflict of interest statement Dr. Wade said that for Nevada 

Test Site the only conflicted person would be Mr. Griffon when dealing 

with an action filed by building trades union. For Savannah River Site 

there are no conflicts. 

*** 

STATUS REPORTS AND DEVELOPMENT OF PLANS FOR SITE PROFILE REVIEWS B
 
NEVADA TEST SITE, SAVANNAH RIVER SITE 

Nevada Test Site Profile Review 

Dr. Arjun Makhijani, 

Sanford Cohen & Associates 

Dr. Makhijani gave a first look and status report of the two 

preliminary site profile reviews now underway, Nevada Test Site and 

the Savannah River Site, for which matrices have been submitted. 

Revision 0 has been reviewed and Revision 1 is in the works. Regarding 

major internal dose issues, the review found there is no internal 

monitoring data until late 1955 or 1956, and NIOSH has not published a 

method by which those doses would be estimated. Radionuclide lists are 

incomplete particularly regarding short-lived radionuclides. The site 

profile recommends use of Technical Information Bulletin 002 for post­
1971 tunnel re-entry workers although the TIB itself says it is not to 

be used for that purpose. Currently, photon doses are used to estimate 

internal doses, raising issues on data integrity and large hot 

particle. Data integrity is in question due to the apparent practice 

of some personnel removing their badges so as not to exceed the 

quarterly dose limit thereby keeping themselves eligible for the high 

pay offered for working in forward areas. 

SC&A’s review questions correction factors used for external dose in 

regard to badge location and job locations. The assumption that 

atmospheric test workers were not exposed to neutrons is unvalidated. 

Although it is true that most workers were kept well away from the 

tests, there were pressures to put personnel in forward areas. Large 

hot particles greater than 10 microns could wind up in the GI tract, a 

situation which Dr. Makhijani’s team feels would be complicated by 

oro-nasal breathing of non-respirable particles. Extensive Naval 

Radiological Defense Laboratory (NRDL) research on the issue of large 

hot particles was cited in the site profile but not discussed. Dr. 

Makhijani offered a correction; the matrix should read Aventing of 
underground tests@ not atmospheric tests. 
The review found many issues regarding environmental dose; these 

methods and models could significantly underestimate the environmental 
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dose by an order of magnitude or more. The resuspension model used in 

the site profile is appropriate only for early re-entry within weeks 

or months but not re-entry after years. Fractionization of 

radionuclides, in which non-volatile radionuclides are deposited 

closer to the test site and volatile radionuclides travel farther, 

needs to be taken into account in environmental dose calculations. 

Gaps in extrapolations in the environmental dose record were not 

deemed appropriate. 

The Nevada Test Site is admittedly complicated but in some essential 

respects the record review and interview process was not complete, 

resulting in gaps in the site profile. The review team was told that 

in interviews, NIOSH only records what it considers important, whereas 

the importance of information is not always evident until later, so 

better documentation of site expert interviews is required. Other 

major issues include radon issues for G-tunnel workers, the status of 

the Gravel Gertie workers, and lack of discussion of radon dose 

issues. 

*** 

DEVELOPMENT OF PLANS FOR NEVADA SITE PROFILE REVIEW 

Questions and comments on the Nevada Site Profile review presentation 

followed. Dr. Makhijani said the information about badges not being 

worn came up in two independent site expert interviews. There are a 

whole set of documents validating these kinds of employment practices.
 
Dr. Ziemer mentioned that before the late 1950’s, lifetime doses were 

not kept. Only weekly limits were noted. Dr. Makhijani said the 

introduction of the integral identification and film badge in 1966 may 

have helped alleviate the situation, but more research is needed. 

Workers in forward areas were given hazard pay. 

Dr. Neton expressed his appreciation for SC&A’s consolidation of the 

report to manageable significant issues. On the monitoring issue, he 

said he’s seen that workers without badge results continued to have 

tritium excreted from the urine, a detail which supports SC&A’s 

contention that badges were often removed. Dr. Ziemer said that would 

be another good way to cross-validate. NIOSH recognizes the gaps in 

the site profiles and is for that reason moving very cautiously with 

dose reconstructions at Nevada Test Site, particularly during the 

above-ground, atmospheric testing era. 

Dr. Makhijani clarified to Dr. Roessler that the radon accumulation 

owed not to the soil, as at Iowa, but to the enclosed structure at 

Nevada. Speaking from the audience, Mr. Mike Molino did not reveal 

his affiliation, but interjected he has been to the test site numerous 
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times and could attest that a Gravel Gertie was used for cover at 

Nevada Test Site for seven balloon shots during the early years. 

***** 

SAVANNAH RIVER SITE PROFILE REVIEW 2 

Dr. Makhijani presented the Savannah River Site Profile Review 2, 

completed in October of 2004, explaining that SC&A has not yet 

reviewed NIOSH’s Revision 3 published April 5, 2005, so some of the 

issues to be addressed here will likely have already been resolved. 

Recycled uranium was one issue. Coverage of radionuclides from the 

transplutonium coverage needs to be fuller; exposure to cobalt-60 and 

an array of other radionuclides need to be considered. Dosimeter 

calibration is on normal incidence, so the question of exposure angles 

needs consideration. Dosimeter adjustment factors used in the Savannah 

River site profile are not consistent with the DOE complex-wide 

recommended factors. Some familiar neutron-to-photon ration and 

neutron dose questions are at issue. The geometric mean and standard 

deviation is not technically defensible or claimant-favorable. 

Variations of these ratios within a given facility, such as the FB-

line, need to be taken into account. SC&A recommended use of the 95th
 
percentile values for the period where there are TLND neutron dose 

data. 

There was an incomplete characterization of the Tank Farms. Many of 

the spills were not entered into a databank. Exposure from ground 

spills relative to badge location could be important. These are 

significant issues and it’s important to try to establish a complete 

list of incidents. This review also details inadequacies in the early 

internal and external monitoring programs. 

Coworker models for early workers have not been developed. Some 

recorded intakes were higher than the high five, so the high five 

seems not always to be an actual high five. There seemed to be an 

inconsistency with the regulation 42 CFR 82. There’s an assumption 

that the high five approach is necessarily the worst-case approach. 

Various factors led SC&A to conclude that its use may result in a very 

high overestimation of the dose in most or all cases, but it is not 

clear this could be demonstrated given the present state of the 

documentation reviewed. 

SC&A also questions the applicability of an off-site source term to 

on-site exposures; it may be appropriate in some but not all 

situations. The review finds a need to improve internal dosimetry with 

regard to radionuclide solubility. Some sources of external dosimetry 

are not being used in the dose reconstruction process. Special 
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exposure circumstances for subcontractors and construction workers 

need to be considered. 

*** 

In the discussion on this review, Dr. Makhijani agreed to provide 

information on additional external dose dosimetry to the Board and 

NIOSH via e-mail. Dr. Ziemer and others attended to wording in the 

minutes regarding a motion and agreement to hold a face-to-face 

session on development of the matrix. It was decided that the minutes 

need to be reworded to indicate it was not an official response. Dr. 

Ziemer did want the Board to be aware that there was an action already 

in place in moving forward on the resolution process, this matrix 

being the first step. Dr. Wade commented that the Board has a great 

deal on its plate and the group must keep the entire field of play in 

view so that other priorities such as SEC petitions do not stop 

progress on any project. He suggested talking about a possible course 

of action for the Nevada and Savannah River Test Sites. 

Dr. Ziemer conducted the formation of workgroups and team leaders for 

each site. (Team leaders are listed first.) Nevada Test Site: Presley, 

Clawson, Munn, Roessler; Savannah River Site: DeHart, Gibson, 

Griffon, Lockey; Hanford Site: Melius, Clawson, Poston, and Ziemer. 

Dr. Mauro offered to prepare a revised matrix that reflects Revision 

3. Without objection, the contractor was ordered to proceed along 

those lines. 

***** 

CONFLICT OF INTEREST DISCUSSIONS 

Dr. Lew Wade, Executive Secretary 

This issue was initiated by a February 20th, 2005 communication from 

Mr. Richard Miller to Dr. Neton at NIOSH and Dr. Toohey at ORAU, 

raising issues about the Paducah site profile conflict of interest 

issues and also technical issues. A contract oversight team issued a 

report dated October 11, 2005. It was made available at the last 

Board meeting, although not discussed. In light of that report, on 

December 9 Mr. Miller corresponded further with Dr. John Howard, 

Director of NIOSH, and Mr. Michael Leavitt, Secretary of HHS, a copy 

of which was provided in the Board members' packets. Dr. Howard
 
responded to Mr. Miller on December 29. As Mr. Miller requested, Dr. 

Howard took a personal interest in this issue, in this case as it 

relates to the ORAU contract. The two basic issues are conflict of 
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interest issues as currently embodied n the draft policy for ORAU, and 

the technical issues raised by Mr. Miller regarding the Paducah site 

profile. Dr. Wade’s suggestion for a format addressing these concerns 

was accepted by Dr. Ziemer. 

***
 
Mr. Elliott began the discussion, explaining he commissioned the 

October review by the assessment team of Mr. Michael Rafky out of the 

Office of General Counsel on the NIOSH radiation legal team; Ms. Lauri 

Ishak, a Presidential management fellow at NIOSH; and Mr. Robert 

Daniels, a health physicist with NIOSH. Their charge was to evaluate 

the concerns raised in the February 20 letter to Dr. Toohey and Dr. 

Neton and determine whether a conflict of interest (COI) policy 

violation occurred during the development of the TBD for the Paducah 

Gaseous Diffusion Plant and whether or not data was purposely excluded 

that should have been incorporated in that site profile. The findings 

of that report are so stated. 

The conflict of interest policy employed during the approval of this 

site profile was found to contain ambiguous language. In the interim, 

this Board raised concerns and ORAU complied with the need to make a 

change in their conflict of interest policy to address site profile 

development. Violation of the then-current COI policy did not occur. 

Although the language was ambiguous, the assessment team felt that the 

underlying intent of the policy was followed. 

Besides ambiguous language, the team identified lack of clear 

definitions of roles, responsibilities, and terms such as subject 

expert, document owner, and primary author. Regarding the technical 

basis of the Paducah site profile, concerns were raised that the 

subject expert did not include a careful consideration and inclusion 

of all data, such as data on ash receivers in the pulverizer area, 

into the presentation of information in the site profile. 

The revised policy as presented today provides much clearer 

explanation and definition of roles and responsibilities and clear 

definitions of terms such as conflict and bias. It identifies clearly 

what the review process is and what level of attribution and 

disclosure is required. 

Ms. Kimpan was invited to speak on this. She expressed pride in the 

work that ORAU is performing for NIOSH on behalf of sick workers and 

said this issue is important to ORAU. It goes to ORAU’s credibility, 

public standing and the quality of the work. Full disclosure is 

paramount. ORAU fully embraces and is implementing this policy even in 

its draft form. ORAU is following the full spirit of the policy, which 
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is that no one who is in a potentially or actually biased or 

conflicted role will be a document owner for any part of the work. 

Mr. Elliott added that his group feels so strongly about this policy 

and its clarity and comprehensiveness that once ORAU finalizes it, it 

will be modified to become the OCAS policy. The policy itself requires 

NIOSH approval. Mr. Elliott welcomes Board input also. 

Board members expressed a need for more time to digest the information 

before taking action on it. 

The dearth of experts in this field could lead to conflicts of 

interest. Proper attribution, transparency and objective, scientific 

criteria will be used to minimize the potentially compromised effect 

of having such a small pool of qualified site experts. Mr. Elliott
 
elected to read the definitions of key distinctions from the draft. 

Offered an opportunity to speak, Mr. Miller said conflict of interest 

taints the science that comes out the door and all associated 

organizations. He opined that this Advisory Board is here today with 

NIOSH doing this work because Congress found they couldn’t rely on the 

Department of Energy to do it. The burden is on this conflict of 

interest policy to have adequate checks and balances due to the 

paucity of a pool of available experts. He suggested conflict of 

interest is not merely financial, as outlined in the newly proposed 

draft. It involves organizational and professional conflicts of 

interest, both of which are omitted from this policy. He urged his 

listeners to treat the draft as a work in progress. He agreed to 

provide his ten-page white paper to Dr. Wade for the Board. It lays 

out in detail a critique of the October conflict of interest draft 

policy and provides, in a side-by-side analysis, guidance on what the 

new policy ought to look like. 

***
 
PADUCAH SITE PROFILE/TECHNICAL ISSUES 

Mr. Stuart Hinnefeld, 

NIOSH 

Numerous items of a technical or scientific nature prompt additional 

investigation. A recent data capture including early documents speaks 

to this issue -- the analysis and identification of non-uranium 

contaminants in the uranium materials in various places. NIOSH has 

instructed ORAU to synthesize this and give NIOSH the best product 

available in light of this discussion. 
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*** 

Discussion Points:
 
#This issue should be resolved quickly for the credibility of the 
program. 
#A plan for NIOSH to develop a procedure for investigating any 
conflict of interest issues that arise. 
#NIOSH staff is being put in the difficult position of investigating 
themselves. 
#Need for an outside involvement mechanism for evaluating the portion 
of COI situations that pertain to NIOSH. 
#Should SC&A also review the revision of the Paducah technical 
document. 
#Dr. Howard's letter requests the Board undertake review of the 
technical quality of the document. 
#The entire document should be reviewed to ensure corrective action 
called for in the assessment report was attended to in the 
revision and all technical information was provided in a new 
revised site profile. 
#Conflict of interest addresses perception, as well as technical or 
legal violations, and even the possibility of a conflict needs to 
be addressed. 
#Perceptions may or may not be valid, such as the assumption that the 
individuals who know most about a topic are the ones to be least 
trusted. 
#A need for management to be up front about possible perceptions and 
state how the issue is being handled. 
#The importance of transparency and how disturbing that conflict of 
interest statements have not been consistently made available. 
#Concern about the terminology limiting conflict of interest to 
financial interest. 
#The policy is written to fit how ORAU works and is not easily 
understood by people outside that group. 
#Conflict of interest training for federal agencies focuses on 
financial conflicts, while this program is more concerned with 
programmatic and related issues. 
#This proposed policy applies to every aspect of ORAU's operations. 
Following Dr. Ziemer's call for a motion to delineate the task to be 

undertaken in response to Dr. Howard's request for Board review, Dr. 

Wade announced the only Board member conflicted on the Paducah site 

was Mr. Leon Owens, who was not present at the meeting. 
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A motion was made and seconded that the Board give SC&A the task of 

reviewing the revised Paducah site profile, with particular attention 

to the issues raised in Mr. Miller's February 2005 letter, as well as 

in the NIOSH assessment of the conflict of interest issues related to 

the original site profile. 

Following discussions related to timing and slowing down work on other 

sites, the sense of the motion was refined to reflect that the work 

would get underway at such time as the materials are available, and 

that the Board will be kept apprised of the status. Even if there is 

a delay of a couple of months to fit the work in, there should be no 

dropping of current plans as this becomes additional work. 

With that clarification, the motion carried unanimously. 

Further Discussion Points:
 
#ORAU's intent to apply the policy retrospectively. 

#It applies to things not actively in the review process, as well as 

what is in the formal review process. 
#The need to keep Board members and the public informed when a change 
is made on a site profile. 
#An obligation to follow up on changing disclosure statements, with 
ORAU making assurances of full status updates and transparency. 

***** 

TASK III REVIEW B DISCUSSION/CLOSURE 
Mr. Griffon gave an update on Task III, the review of the procedures 

task. On Tuesday, the subcommittee, having previously reviewed the 

procedures related to external dose, reviewed the procedures focused 

on internal dose and the CATI interview procedures. Any comments not 

agreed upon in the NIOSH response column of this matrix were pushed 

into the workgroup process for in-depth discussion. They want to 

cross-walk any procedures that have been replaced to be sure none were 

lost. At behest of the Board, Dr. Wade amended the contract to see 

that OTIB-4, the latest release, is added to the list; ORAU-0097, Rev. 

00; and ORAU-0031. These will be added to the new list or procedures 

to review that is already in place. When it is completed, Ms. Behling
 
will e-mail to the Board the list of new procedures containing 

information on where there are workbooks associated with the various 

documents. Dr. Mauro said work and assignments on the originally 

authorized 33 procedures has begun, but they have found that some of 
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those do not need review and some have already been reviewed so he 

will transmit to the Board a recommendation for replacements and 

additions and the reasoning behind them. Mr. Griffon hopes to finalize 

these internal dose and CATI interview resolutions at the next 

workgroup meeting, date yet to be set so a determination of the scope 

can first be made. 

*****
 
INDIVIDUAL DOSE RECONSTRUCTION REVIEWS 

Mr. Griffon summarized the status of individual dose reconstruction 

reviews. The Board has closed out on the first set of 20 cases and the 

Board’s acceptance letter is drafted and hopefully en route to the 

Secretary of the HHS. It will also be posted on the internet. The 

second set of 18 is the next case review item for the workgroup as 

they have not had a chance to review NIOSH’s responses. NIOSH has just 

received the findings for the third set of cases so time is needed for 

their response, and SC&A has competed reviews on the fourth set and is 

ready to do the team conference calls with the groups for which new 

assignments are needed. 

*** 

REVIEW AND APPROVAL OF BOARD MINUTES
 
Discussion was held on minutes for the August 2005 meeting. Dr. 

Ziemer noted that although the minutes are abbreviated from 

transcripts, the motions themselves should be full and complete. 

A motion was made and seconded that the minutes for the August meeting 

be approved as modified. The motion carried unanimously. 

*** 

It was agreed the minutes for the October meeting would be modified to 

add Mr. Leon Owens' name to the list of attending Board members. 

A motion was made and seconded to approve the minutes for the October 

meeting as modified. The motion carried unanimously. 

***** 

BOARD WORKING TIME 

Recognition of Departing Members 

Future Meetings and Plans 
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Dr. Ziemer formally recognized the careers and contributions of two 

outgoing Board members, Mr. Richard Espinosa and Dr. Henry Anderson. 

Both were awarded a certificate of recognition from the HHS and a 

letter signed by Dr. Julie Gerberding, Director of the CDC, and Dr. 

John Howard, Director of NIOSH. 

*** 

Ms. Kimpan updated the group on her response to a substantive concern 

raised this morning concerning a new disclosure form that had less 

information that the prior form. She tasked her people to check for 

consistency of the first and second forms. Information is being 

corrected on the ORAU web site. 

***** 

SEC RULE REWRITE 

Mr. Ted Katz, 

NIOSH 

Dr. Wade proposed options for dealing with the rule comment period 

closing February 21. He asked Mr. Ted Katz to describe the changes for 

elucidation only. 

As background, Mr. Katz explained that in December 2005 HHS published 

amendments to its Special Exposure Cohort rule. That rule is presently 

open to public comment until February 21st, but was made effective 

immediately as a provisional rule and open to changes on the basis of 

public comment before it is finalized. He read verbatim Section 

73.84(q)(c), the rules on deadlines. Two changes were made to make it 

compliant with new statutory requirements. The first was to establish 

the definition of a petition in the rule. Under 83.8 it means a 

submission that meets all the requirements and has incorporated any 

revisions made and added any material needed for the petition to 

qualify. 

After a petitioner works with NIOSH and submits a petition and makes 

whatever revisions are needed, if the petition still doesn't quality 

at the end of that process, NIOSH notifies them and they have the 

right to request a review of that decision. Previously there was a 

30-day period to request that review. The second change reduced that 

period to seven days. 

The reason for the change is because the 180-day counting period for 

action on the petition is based on when the petition met the 
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requirements and became a proper petition. In the event NIOSH 

determined the petition didn't qualify and the petitioner's appeal for 

review determined NIOSH to be in error so that the petition had 

actually qualified earlier, the period of time expended on appeal and 

review would have eaten into the 180-day period for evaluation. This 

is important because the time constraints are already great. 

Another provision is regarding the finding of feasibility and health 

endangerment. After a petition is evaluated and the Board has made a 

recommendation and there's been a proposed decision by the Director of 

NIOSH, the petitioner had an opportunity to seek a review of that 

proposed decision. However, the 30 days allotted wouldn't allow for 

the petitioner to bring the request, let along do the review and come 

to a final decision. That has now been moved to the end of the 

process and the Secretary will make final decisions. However, those 

decisions will have the same review rights the proposed decision had 

before. 

Additionally Congress is requiring a report of both affirmative and 

negative decisions or determinations. And finally Congress has 

changed their 180-day period to review the Secretary's proposals to 

add new classes to 30 days, so that change is included in the rule. 

The Board devoted considerable discussion to the reduction of a 

petitioner’s review request time to come to a full comprehension of 

what this means in terms of process and fairness. It was decided that 

the language is not clear. Five issues of strong concern over this 

rewrite emerged, including the 7-day petitioner appeal, the meaning of 

timeliness, the interpretation of the 180-day limit and the issue of 

the time frame to qualify. Dr. DeHart suggested that a lead be 

appointed to gather the proposed comments, and Dr. Melius volunteered. 

Dr. Ziemer suggested he put together a categorized response for Board 

consideration prior to a conference call. Without objection, the Board 

will follow that pattern with Dr. Melius having the lead. 

It was then decided to request extension of the public comment period 

past March 14th, at which time this will be one of the items for the 

Board phone call scheduled for that date. 

***** 

Dr. Melius read into the record his proposed letter for the Department 

of Justice concerning the Board’s desire for written legal advice 

while maintaining a process consistent with the original intent of the 

EEOICPA legislation. 
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A motion was made and seconded that the subject letter be sent to the 

Secretary of HHS. 

Discussion followed, during which the wording rather than intention of 

the letter seemed to be at issue; Board members were concerned about 

how to express, acknowledge and work with the fact that petitioners 

may want what is in fact classified information. 

The letter was amended to include the comment that AWhile the Board is 
fully supportive of the need for preventing the release of classified 
or restricted information and recognizes the necessary use of such 
information in the DOE nuclear program, the Board also recognizes..@
With that change, the motion carried. 
*****
 
TASK III REVIEW B DISCUSSION/CLOSURE 
The Board entered discussion to formulate its decision on Task III 

concerning assignments to make to the contractor on their SEC petition 

evaluation task. Participants clarified the status of various site 

projects, terminology for the work to be done and its relation to SEC 

work now underway, the nexus of SC&A’s involvement with NIOSH in terms 

of timing and series or parallel efforts, options for the tasking 

procedures, consideration of personnel resources given time 

constraints, the formation of workgroups for the various sites, and 

the spirit and intent of Task III. It was determined that Y-12, Rocky 

Flats and Ames, all of which have qualified SEC petitions, are the 

most suitable choices for concurrent additional work by SC&A due to 

their upcoming 180-day deadlines and relative clarity of issues for 

SEC petitions at the first two. Site profile work and SEC petition 

questions can be addressed concurrently and efficiently by early 

information sharing between SC&A, NIOSH and possibly a workgroup. The 

workgroup assignments include Mr. Griffon’s workgroup for Y-12 and 

Rocky Flats and a new workgroup for Ames including Dr. Melius as 

chair, Dr. Lockey and Ms. Munn. Dr. Wade summarized by saying he would 

deal with the contracting officer to issue three tasks under the SEC 

task of the SC&A contract. One will be a total review of Ames. The 

specific action there will be to schedule a meeting of NIOSH, SC&A and 

the Ames workgroup, respectful of peoples schedules. Also, two task 

orders will be ordered for focused SEC reviews for Y-12 and Rocky 

Flats, and the substance of those will be the opened issues identified 

by the workgroup in the high priority matrices. 

Mr. Griffon asked if the Board will be asking SC&A to assist with 

Pacific Proving Ground. Dr. Ziemer said Mr. Presley has volunteered to 
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represent the Board at the meeting with DTRA. Dr. Neton will FedEx a 

copy of the Y-12 CD data to the working group and SC&A; there is no 

problem in sharing it under the provisions of the Privacy Act. SC&A 

will have it in case the workgroup needs to ask their assistance for 

the meeting tentatively set for February 27th . Dr. Melius made the 

point that Task V authorization requires direction. Dr. Wade clarified 

that any immediate work can be done under the site profile task and he 

will work with dispatch to get an SEC focused task for Y-12 that will 

cover the continuation of work. Dr. Mauro commented that during the 

presentations of Rocky and Y-12 it’s not always apparent which of the 

items represent site profile issues. One of the big challenges in 

streamlining and expediting the process will be to quickly come to a 

common mind regarding which issues are SEC issues so a focused assault 

can be designed. He didn’t know if there would be universal agreement 

right now if a discussion were held on this matter. He has a clearer 

idea of what he believes to be SEC issues on Rocky Flats than on Y-12. 

Dr. Wade said he’ll take his lead on that task order from the chair of 

the working group and then dialogue with Dr. Mauro, who expressed his 

sense that the process will involve a great deal of iteration because 

the investigations will lead to a point where it’s believed a dose 

reconstruction can be done but they do not know exactly how to do it. 

It will be a matter of identifying SEC issues as clearly as possible 

and agreeing on what degree of conservatism can be used. 

*****
 
PROGRAM UPDATE -- NIOSH
 
Mr. Larry Elliott, Director 

Office of Compensation Analysis and Support 

Mr. Elliott presented NIOSH’s program and science issues updates 

according to the slide presentation and handouts. He reported the 

completion of 12,264 draft dose reconstruction reports as of January 

13, 2006, although he wished they could have done more. The number of 

active claims, 486, has changed since January; all these numbers are 

fluid. Of note are the proposed changes to the target organ for 

reconstructing dose for lymphoma cases about which the Board approved 

a draft of this OCAS TIB on January 9th. The comment period closes 

February 4th, he believes. About 1,000 claims will be affected one way 

or another by this change. Mr. Elliott is working closely with Ms. 

Kimpan on making sure comments from the public comment period are 

being addressed, and she in fact will be following up on items from 

this Board meeting tomorrow. He noted that NIOSH still takes many 

claimant and stakeholder phone calls as well as e-mails, to which they 

try to respond within 24 hours. There were no questions. 
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***** 

PROGRAM UPDATE -- DEPARTMENT OF LABOR 

Dr. Diane Case, 

Department of Labor

Dr. Case’s statistics were represented on her slide show and handouts. 

She elucidated on the terms claims and cases. A case refers to an 

individual employee’s case, which can contain more than one medical 

condition and have one or more claimants on that, the survivors. Most 

of the claims they receive are for conditions that are non-covered. 

The next majority of claims they receive are for cancers. 

After her presentation, Dr. Melius commented on the difficulty of 

communicating these programs to the claimants, who have been told it’s 

an easy process with NIOSH ready to assist them. Once they get into 

Subtitle E program, they suddenly have to produce a great deal more 

information on disabilities as well as sometimes on medical and 

exposure. He wondered if anything can be done to facilitate the 

process beyond the town meetings. He also wanted to put on the agenda 

for the next meeting the issue of how to deal with the non-SEC 

cancers, such as determining when it will be feasible to reconstruct 

certain types of cancer and certain exposures in the situation where 

we are also approving a Special Exposure Cohort. It’s tricky and could 

create a lot of unnecessary work. Finally, he wanted to be sure that 

future presentations include the number of cases coming back from the 

DOL to NIOSH for reworks so any potential problems in the program can 

be addressed. Dr. Case replied that her rough estimate is 450. A small 

percentage get through that never should have gotten through and they 

were fine, but a majority of them have to do with the claimant not 

bringing information forward after the dose reconstruction has been 

performed. She will be sure to include that information in the next 

presentation. 

*** 

In the spirit of transparency, Dr. Wade made an update that in the 

fourth round of reviews by SC&A they identified three cases where 

overestimating assumptions were used in error which could possibly 

impact compensation decisions, so the cases will be re-opened and re­
evaluated. He will keep the Board posted. He thanked SC&A for that 

effort and felt it indicates the benefit of the audit program. Dr. 

Ziemer clarified that although the audit is not intended to be a 

process for reopening claims, if something is identified that could 
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have a significant impact, it is prudent that the contractor at least 

alert NIOSH to this as soon a possible before the review process has 

been completed. This type of early alert, although not covered in 

procedures per se, exemplified the intent to identify systemic issues 

and process procedures. 

***
 
Scheduling plans were announced for a March 14 phone call at 10 a.m. 

Eastern time which will include new Board members; the face-to-face 

Board meetings April 25, 26 and 27; other Board meetings to be set for 

June and early October. Board members will be contacted with exact 

dates once the new members are fully vested and clearances complete; a 

phone call in between the face-to-face meetings to deal with items 

requiring immediate attention. Mr. Griffon’s workgroup meetings are 

scheduled for February 13th, 9:00 to 4:00 in Cincinnati for a 

procedures review, the second and third sets of cases; February 27th
 
9:00 to 4:00 for Y-12 and Rocky Flats SEC. Because those meetings will 

be open to the public and not held in NIOSH’s offices, Dr. Wade
 
suggested that the other chairs of working groups look at those dates 

and consider combining meetings to simplify logistics since a hotel 

facility will need to be secured. He agreed to e-mail dates and 

committee information to everyone. 

Dr. Ziemer adjourned the meeting at 4:05 p.m. 

* * * * *
With no further business to come before the Board, the meeting was adjourned.
End of Summary Minutes 
Ë Ë Ë Ë Ë
I hereby confirm these Summary Minutes are 
accurate, to the best of my knowledge. 
Paul L. Ziemer, Ph.D., Chair 
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